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Abstract 
 
The review provides a broad overview of amino acid chlorides in peptide chemistry, classified 
into different sections comprising reagents, N-protected amino acid chlorides (preparation and 
properties), coupling employing various protocols and applications in difficult and hindered 
couplings. The recent developments include their applications in synthesis of various amino acid 
derivatives, peptidomimetics, heterocycles and biologically active molecules. 
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1. Introduction 
Acid chlorides as peptide coupling agents has its origin in Emil Fischer’s era with the 
first report of N-protected dipeptide of glycine synthesis emerging in 1903 by Emil Fischer.1 
Soon the octadecapeptide [Leu-(Gly)3-Leu-(Gly)3-Leu-(Gly)9-OH, 1907] of Emil Fischer2 and 
the nonadecapeptide of Abderhalden and Fodor3 were successfully obtained by the same method. 
Their journey until 1980’s has been roller coaster where upon acid halides were considered as 
overactivated species and labeled as “obsolete” in peptide chemistry. The incompatibility of acid 
halide activation with the protecting groups,4 as well as conditions of coupling which may lead to 
racemization were majorly due to dearth of technologies to overcome those limitations and were 
quite exaggerated. Though newer techniques were blossomed in the hands of peptide chemists, 
these didn’t address the concerns related to the acid halide activation strategy for a very long 
time. Also acid halide activation faced severe competition and criticism due to the availability of 
myriad fancy reagents. With seminal contribution of Louis Carpino on acid chlorides of Fmoc 
amino acids, the inertia surrounding the stability aspect of acid halides as coupling agents was 
brushed away by the isolation of shelf stable Fmoc amino acid chlorides and their successful 
application in peptide bond formation.5 In fact, the so called “over activation” is turned out to be 
a boon in the synthesis of sterically hindered peptides in the years followed. Since then, the acid 
halides have been at the forefront of armamentarium of peptide chemists in difficult synthesis 
from being redundant.   
Subsequently amino acid fluorides were developed and found to be sufficiently stable to 
tertiary bases and can also be employed in coupling in absence of a base effectively.6-10 
Oxazolone formation was scant or absent in the presence of a tertiary base. Acid fluorides were 
efficient in both solution and solid phase synthesis of peptides incorporating even acid labile 
protecting groups. However for the coupling of highly hindered substrates utility of acid 
chlorides prevail on to that of acid fluorides. Though the acid fluorides are of significance as 
evidenced by their utility in critical synthesis of some bioactive peptides, a broad discussion of 
their chemistry is out of the scope of this review. 
  Amino acid bromides are highly reactive species which are more reactive than acyl 
chlorides towards amines (up to two orders of magnitude). Acid bromides have been utilized 
successfully for the synthesis of peptides containing α–trifluoromethyl (α–Tfm) or α–
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difluoromethyl (α–Dfm) amino acids and N-Me-amino acids.11-17 However acid bromides are 
underutilized thus far. This is mainly because of the non availability of suitable brominating 
reagent, even for their generation in situ. 
The pronouncement of acid chloride method as ‘overactivation’ (as illustrated by 
Brenner)18 or unattractive (as summarized by Bodanszky)19 or obsolete (as concluded by Jone)20 
has been quite overstated. What is needed is the following: both the conditions for preparation of 
acid chlorides as well as coupling required to be compatible with nature of Nα, Cα and side chain 
protecting groups. In other words, choosing appropriate protocol is a must for obtaining the 
target molecules with chiral homogeneity.  
With the advent of in situ acid halide generating reagents such as 
bis(trichloromethyl)carbonate,21 1-chloro-N,N,2-trimethyl-1-propen-1-amine,22 N-
[chloro(dimethylamino)methylene]-N-methylmethanaminium chloride (TMUCl Cl),23 simplified 
work up and purification procedures were developed which offer quite a solution to the problems 
pertaining to reactivity and difficult coupling as faced by peptide community over a long period. 
Acid halides have turned out to be the most efficient coupling strategy in terms of chemistry and 
atom economy.  Also acid halides have been the trouble shooter in some of latest relevant 
peptide syntheses. Thus today, acid halides are the most bankable coupling activation strategy 
particularly for the assembly of difficult peptide sequences. The acid halides have now grown 
from mere peptide coupling agents to valuable candidates for a variety of difficult acylation 
reactions. 
The last review on the topic has been Louis Carpino’s work in which he had summarized 
primarily his group’s contributions in an account in 1996.24 Also, not a comprehensive coverage 
is found in the chapters regarding acid halides in various books.19, 25-30 Various reviews31-36 have 
been published on peptide coupling reagents, however without the essential depth in acid halide 
activation. The applications of acid halides have generated impressive number of publications in 
recent past (i.e., after Louis Carpino’s account) and there is no update in the review literature 
regarding the recent developments in critical applications of acid chloride activation in the 
assembly of biologically active molecules. Thus, there is a need of a review encompassing the 
origin, significance and relevance of acid halides in peptide chemistry, which could be termed as 
a “black swan event” being revolutionized by Louis Carpino. The present review focusses on 
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essentials of origin and development of acid chloride chemistry, as well as contributions after 
Louis Carpino’s account surveyed till 2014 and thus in all the journey of acid chlorides over a 
century.  
 
The objectives of the review are to provide broad overview of acid chloride activation in 
peptide chemistry, which has not been dealt with the requisite attention thus far and a full 
pledged article on this topic has been elusive in the literature. The review covers wholesome 
aspects of acid chlorides in peptide chemistry classified into different sections comprising 
reagents, N-protected amino acid halides, coupling employing various protocols and applications 
in difficult and hindered couplings. In addition to synthetic methodology and coupling protocols, 
the review highlights diverse applications which include synthesis of peptidomimetics, 
biologically active drugs, natural products and as chiral auxiliaries in synthesis of enantiopure 
intermediates. Total synthesis of various biologically active cyclic peptides including 
cyclosporins O and A, omphalotin A, and petriellin A possessing N-methyl amino acids in their 
core structure involved in situ acid chloride activation as an important feature. Distinct 
advantages of acid halides over a range of peptide coupling reagents in terms of hindered 
couplings have been utilized in recent significant contributions, which gave them decisive edge 
over other methods. 
With our expertise in acid halides, we want to put forth the legacy details as well as the 
growth of the acid chloride chemistry and highlight their relevance in today’s synthetic peptide 
chemistry.  
A broad picture of several protocols available for both the preparation as well as the 
coupling using acid chlorides is furnished in scheme 1.  
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Scheme 1. Various protocols employed for the preparation as well as the coupling using acid 
chlorides. 
Unlike active ester and anhydride methods, the preparation of acid chlorides itself require 
attention. Altogether, the following criteria are very significant with respect to the use of acid 
chloride method in peptide chemistry.37-44 
(1) selection of chlorinating agent: conditions required for the formation of acid chloride, i.e., 
temperature, quantity of reagent, duration of conversion, properties of other products (eg., CO2, 
SO2, POCl3, etc) and their complete removal. 
(2) the necessity of base and of course, its nature for preparation of acid chlorides  
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(3) shelf stability of acid chlorides for storage which in turn depends on nature of Nα-protecting 
group. Parallelly the acid chloride can be generated in situ for immediate use. 
(4) coupling conditions chosen play extremely key role in terms of oxazolone formation (or 
otherwise) which can lead to racemization. In essence, the coupling being carried out using (i) an 
equimolar quantity of an organic base or ii) under Schotten-Baumann conditions or iii) mediated 
by non Schotten-Baumann conditions determines the oxazolone formation. 
(5) the use of either an equimolar quantity of an organic base or Schotten-Baumann conditions 
for coupling and the properties of Nα-protecting group; in particular, when the coupling duration 
need to be extended (for insertion of sterically hindered amino acids/residues). The use of base 
labile group and the coupling under basic conditions lead to the premature deblocking of Nα-
protecting group. 
(6) monitoring of coupling eg., polarity of 9-fluorenylmethoxycarbonyl (Fmoc)-amino acid 
chloride vs the product are almost similar in many cases.  
To summarise, it is to understand that the optimum conditions need to be chosen for both 
efficient as well as practical utility of the acid chloride method. Suffice to point out that this 
primarily depends on the nature of the target molecule itself. 
2. Chlorinating reagents  
Acid chlorides provide simple and economical way to accomplish activation of a 
carboxylic group towards acylation. This makes the carbonyl group highly electrophilic and 
reactive towards both nitrogen as well as oxygen nucleophiles. Numerous reagents have been 
developed over the years to bring about acyl chloride formation. Thionyl chloride, oxalyl 
chloride, phosphorous trichloride, phosphorous oxychloride, phosphorous pentachloride, 
pivaloyl chloride, phthaloyl dichloride, phosgene are the commonly employed reagents for the 
preparation of acid chlorides in organic synthesis (Fig. 1).45-51 The harsh conditions including 
elevated temperatures employed during acid chloride preparation using PCl5 or SOCl2 leads to 
side reactions. The isolation of pure products in case of reagents PCl5, POCl3 is also 
cumbersome. However, SOCl2 is the most frequently used one in amino acid chemistry. The 
formation of undesired product HCl in the above cases is detrimental for acid sensitive Boc, Cbz 
and tBu protecting groups; thereby dictating the selection of reaction condition to be chosen for 
preparation involving acid sensitive functionalities. The use of iminium chloride reagent N,N-
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dimethylchloroformimidinium chloride has been limited primarily in phthaloyl and Cbz 
chemistry. 
N
Cl
H
ClNMe2
Cl
Vilsmeier reagent
1-chloro-N,N,2-
trimethyl-1-propen-1-amine
O N
NN
N
H
O O N
NN
Cl Cl
Cl
modified Wang resin supported cyanuric chloride
N
Cl
N
Cl
TMUCl Cl
Cl Cl
3,3-dichloro-1,2-dimesityl-cyclopropene
O
bis(trichloromethyl)carbonate (BTC)
N N
NCl
Cl
Cl
cyanuric chloride
OO Cl
Cl Cl
Cl
ClClN N
NH3CO
OCH3
Cl
2-chloro-4,6-dimethoxy-
1,3,5-triazine (CDMT)
5 6
7
9
8
11
10
12
 
Figure 1. Chlorinating reagents employed in peptide chemistry. 
 
Cyanuric chloride 552 and 2-chloro-4,6-dimethoxy-1,3,5-triazine 6 (CDMT, Fig.1),53 are 
useful halogenating reagents which give rise to neutral side products thereby compatibility with 
the tBu side chains in amino acid chemistry is achieved. Due to weak basicity of the triazine 
moiety, the byproduct cyanuric acid and excess coupling reagent present, if any, can be removed 
by simple filtration followed by washing with diluted acids.  
Bis(trichloromethyl)carbonate 7 (BTC or triphosgene)21 was employed by Falb et al. as in 
situ chlorinating agent in combination with collidine as a base at 50 oC in inert solvents such as 
tetrahydrofuran (THF), 1,4-dioxane to obtain Fmoc amino acid chlorides containing acid labile 
side chains (both proteinogenic and N-alkyl amino acids). BTC in combination with 
diisopropylethylamine (DIEA) and collidine is exceptionally useful for coupling of sterically 
hindered N-alkyl amino acids in the synthesis of hinderd polypeptides.  
Devos et al. developed an extremely benign reagent system tetramethyl-α-chloroenamine 
8 (1-chloro-N,N,2-trimethyl-1-propen-1-amine),22 devoid of formation of HCl in acid chloride 
preparations. This will concord the presence of acid sensitive tBu groups and wide range of other 
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protecting groups. Vilsmeier reagent 9 was employed as an efficient chlorinating agent which 
can be prepared by combination of N,N-dimethylformamide (DMF) with phosgene or SOCl2 or 
(COCl)2. 1-Chloro-N,N,2-trimethyl-1-propen-1-amine 822 as well as Vilsmeier reagent 954 have 
been employed for the in situ generation of amino acid chlorides (Scheme 2).  
Recently in an interesting study, Hardee et al. employed 3,3-dichloro-1,2-
dimesitylcyclopropene 10 for generation of acid chlorides in presence of DIEA by aromatic 
cation activation.55 N-[Chloro(dimethylamino)methylene]-N-methylmethanaminium chloride 11 
(TMUCl Cl) was developed by Albericio et al. for the solid phase preparation of anilides from 
carboxylic acids.23 Also a modified Wang resin supported cyanuric chloride 12 has been 
demonstrated for amidation of Boc amino acids through acyl chloride route albeit with complete 
racemization.56 
 
Scheme 2. Commonly employed reagents for acid chloride formation and the mechanism of 
activation. 
3. Preparation and properties 
3.1. Urethane protected amino acid chlorides 
3.1.1. Cbz- and Boc-chemistry 
The general synthesis of benzyloxycarbonyl (Cbz)-amino acid chlorides 21 is primarily 
marked by the instability as well as the loss of stereochemical integrity through base catalyzed 
oxazolone formation 22 (Scheme 3).57-60 Stable Cbz-amino acid chlorides 21 can be prepared at 
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low temperatures using PCl5, however get converted to the corresponding N-carboxyanhydrides 
23 (NCAs) slowly on shelf (Scheme 3). Also the removal of unwanted product POCl3 from the 
acid chloride product is known to be tedious.61 SOCl2 usually gives acid chlorides at high 
temperature, hence considered unsuitable for the synthesis of Cbz-amino acid chlorides 21.  
N
O OPhH2CO
R
21 22
N R
ClO
O
O
H
base
oxazolone
decomposition
at elevated temperature N
O OO
RH
+ C6H5CH2Cl
Leuchs anhydride21
23
H
N R
ClO
O
O
 
Scheme 3. Formation of oxazolone and Leuch’s anhydride from Cbz-amino acid chloride. 
The use of 1 : 1 mixture of SOCl2 : benzotriazole permits the preparation of acid chlorides at 
room temperature.62 This procedure seems attractive for the synthesis of stable Cbz-amino acid 
chlorides at room temperature thereby alleviating the high temperature conditions which will 
lead to their decomposition to NCAs 23.63 Of course, the resulting acid chlorides need to be 
utilized soon after its preparation which circumvents their decomposition on shelf storage.  
NCAs were first discovered by Leuchs and coworkers, when they tried to purify N-
ethoxycarbonyl or N-methoxycarbonyl amino acid chlorides by distillation.64-66 
  Schmidt et al. developed a simple protocol for in situ generation of acid chlorides from 
Cbz-amino acids as well as Cbz-oxycarboxylic acids at 0 oC by employing 1-chloro-N,N-2-
trimethyl-1-propen-1-amine 8.67,68 The acid chlorides thus formed were free from tertiary bases, 
HCl and their salts. The byproduct N,N-dimethylisobutyramide was separated from the crude 
desired product by distillation or by silica gel chromatography. Matsuda et al. employed 
dicyclohexylammonium (DCHA) salts of Cbz-protected amino acids for in situ generation of 
acid chlorides at room temperature using SOCl2 and pyridine within one min.69 But the study 
involved Ala, Phe, Val, Leu, Glp and Glu(OEt) only. In other examples involving Cbz group, 
bis-Cbz-glycyl chloride 25 (N,N-bisbenzyloxycarbonyl-glycyl chloride) was prepared in situ by 
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reaction of oxalyl chloride on N,N-bis-Cbz-Gly 24 and was utilized directly without isolation 
(Scheme 4).70 Also Cbz-Glu protected as oxazolidinone 26, was refluxed with excess SOCl2 to 
obtain the corresponding -acid chloride 27.71,72 
N COOH
(COCl)2
CH2Cl2
rt, 3 h
N Cl
O
Cbz
Cbz
Cbz
Cbz
24 25
 
CbzHN
O
H
O
yield = 78%
COCl
 excess SOCl2CbzHN
O
H
O
COOH
reflux
26 27
20 min
 
Scheme 4. Synthesis of bis-Cbz-glycyl chloride and -acid chloride of Cbz-Glu protected as 
oxazolidinone. 
 As in the case of Cbz chemistry, preparation of tert-butoxycarbonyl (Boc) amino acid 
chlorides posed problems concerning both stability and stereomutation. There are only a couple 
of reports regarding the synthesis of Boc-amino acid chlorides.73 The attempts to prepare Boc-
Phe-Cl using modified Wang resin-supported cyanuric chloride 12 had met with limited 
success.56  
       Interestingly, recent attempts with the use of 3,3-dichloro-1,2-dimesitylcyclopropene 10 as a 
chlorination reagent in presence of DIEA as the base is quite promising with encouraging 
prospects.55 Recently, the reagent is used for the conversion of carboxylic acids to their acid 
azides, which are later converted into ureidopeptides through Curtius rearrangement.74 
3.1.2. Fmoc chemistry 
The first illustration of Fmoc amino acid chloride 29 was evidenced in a tertiary amide 
bond formation as reported independently by Cohen75a and by Pass et al.75b But neither they were 
isolated nor characterized by them. Finally in 1984, Carpino successfully applied SOCl2 method 
to Fmoc amino acids 28 leading to the isolation of corresponding acid chlorides 29.5 A 0.1 eq of 
DMF as catalyst accelerated the conversion which was complete within 1 h at room temperature. 
The participating chlorinating agent here is N,N'-formamidinium chloride. All the Fmoc-amino 
acid chlorides from proteinogenic amino acids were isolated as crystalline solids, none of them 
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were found as oils (Table 1). They were found to be shelf stable, could be stored for months in a 
desiccator at room temperature without perceptible decomposition. Fmoc-amino acid chlorides 
show characteristic vibrational stetching band (KBr) at around 1790-1810 cm-1.  
 
Table 1 List of Fmoc-protected amino acid chlorides 
R
FmocHN
O
OH
R
FmocHN
O
ClSOCl2 , DMF
CH2Cl2, rt
28 29
 
Amino acid Yield (%) mp (oC) Amino acid Yield (%) mp (oC) 
Gly 95.4 108-109 Lys(Cbz) 88.3 67-68 
Ala 80.6 112-114 Phe 95.8 120-121 
Ile 87.3 103-104 D-Phe 92.5 119-120 
Pro 78.6 93-94 Leu 96.0 80-81 
Val 85.3 111-112 Tyr(Bn) 91.2 114-115 
Met 90.3 118-119 Ser(Bn) 90.8 96-98 
Cys(Bn) 95.2 104-105 Asp(Bn) 89.3 50-53 
* Yields given are of the pure isolated chlorides following recrystallization from CH2Cl2-hexane. 
Several Fmoc-N-methylamino acid chlorides, Fmoc-dialkylamino acid chlorides were 
also reported by employing SOCl2 method at room temperature in moderate to good yields.76 All 
these compounds were obtained as solids and were shelf stable under anhydrous conditions. 
Although not isolated, Fmoc-δ-aminovaleryl chloride (Fmoc-δ-Ava-Cl) was also prepared.77-79 
The synthesis of Fmoc-amino acid chlorides80 29 has been found to be accelerated by 
ultrasonication at room temperature, and corresponding acid chlorides could be obtained in 25-
55 min in good yields and purity.81,82  
Benoiton et al. demonstrated that mixed anhydrides of Fmoc-amino acids could be 
converted into corresponding acid chlorides by anhydrous HCl in contrast to that of Cbz- as well 
as Boc-protected amino acid mixed anhydrides which will convert into corresponding NCAs.83 
Activation of Fmoc amino acids with isopropyl chloroformate (iPrCF) followed by treatment 
with anhydrous HCl (Scheme 5; method A) provided corresponding acid chlorides along with 5-
20% of ester byproduct 31 depending on the amino acid employed. However, Fmoc-Phe-
OCO2iPr and Fmoc-Val-OCO2iPr gave ester free acid chlorides in good yields. The tert-butyl  
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esters and tert-butyl carbamido groups did not survive, though varying percentages of intact 
ether function were obtained from Fmoc-Ser(tBu)-OH and Fmoc-Thr(tBu)-OH. Also depending 
on the nature of the alkyl group varied amounts of ester was obtained as side product. The side 
reaction could be eliminated by employing isopropenyl chloroformate (iPreCF; Scheme 5; 
method B), as acetone is generated by the liberated alkoxy group. The optical integrity of the 
Fmoc-Val-Cl (chosen as a model substrate) obtained by mixed anhydride method was 
established by reacting it with HCl.H-Val-OEt/NMM followed by determination of the epimeric 
content of the products by RP-HPLC, where it showed <1% of D-isomer.  
The list of Fmoc-amino acid chlorides made include Leu (yield = 78%), Phe (yield = 
78%), Ile (yield = 74%), Lys(Cbz) (yield = 83%), Glu(Bn) (yield = 80%), Ser(tBu) (yield = 82%) 
and  Thr(tBu) (yield = 82%).  
FmocHN COOH
R
iPrCF
NMM
iPreCF
NMM
FmocHN
R
O
O
O
O
FmocHN
R
O
O
O
O
dry HCl
FmocHN
R
Cl
O
OH
FmocHN
R
O
O
5-20 % 
byproduct
dry HCl
FmocHN
R
Cl
O
acetone + CO2
dry HCl N
OFmO
O
HR
Method A
Method B
31
28
30
29
32 29
 
Scheme 5. Synthesis of Fmoc-amino acid chlorides from mixed anhydrides. 
Significantly, the in situ generation of Fmoc-amino acid chlorides using BTC lead to the 
conversion of Met, Arg(Pmc) (Pmc = 2,2,5,7,8-pentamethylchroman-6-sulfonyl), 
Asp/Glu(OtBu), Cys(Trt) (Trt = trityl), Gly, L/D-Lys(Boc), Ser-/Thr-L/D-Tyr(OtBu), Trp(Boc) to 
the corresponding acid chlorides. However, the attempts with respect to Fmoc-His(Trt) and 
Fmoc-Asn(Trt) were futile.84 
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3.1.3. Other urethane protecting groups 
Several other reported urethane protected amino acid chlorides include 2-(tert-
butylsulfonyl)-2-propenyloxycarbonyl (Bspoc) amino acid chlorides,85 and propargyloxy 
carbonyl (Poc) amino acid chlorides,86 {[2-(tri-phenylphosphonio)ethyl]oxy}carbonyl (Peoc) 
amino acid chlorides87 and Etoc-amino acid chlorides.88-90 Their preparation and properties are 
enlisted in the table 2. 
 
Table 2 Other urethane protected amino acid chlorides: Preparation and properties 
 
Entry Protecting group Reagent/Reaction condition Amino acid chlorides 
1 
O
O
 
Etoc 
(COCl)2, DMF, 0 oC88,91,92 Ala (97%, yellow oil)54,93 
Val (98%, colourless oil)54 
Pro (98%, colourless oil)54 
Phe94 
N-MeAla95,96 
 
H3C O
O
 
MeOCO 
(COCl)2  in CH2Cl2, 0 oC to 
room temperature95,96 
PCl5 in ether, 0 oC 
Ala95 
2 
O
O
S
O O
 
Bspoc 
SOCl2 in CH2Cl2, room 
temperature85 
Phe (82%, mp = 100-100.5 oC) 
Gly (91%, mp = 61.5-62.5 oC) 
 
3 
O
O
 
Poc 
SOCl2 in CH2Cl2, room 
temperature86 
Phg, Phe, Ala  
(Acid chlorides were found stable and 
storable at room temperature under 
anhydrous conditions for several 
days.) 
4 
O
O
P
Ph
Ph
Ph
 
(COCl)2 in CH2Cl2 at 0 oC to 
room temperature87 
Val, O-Peoc-hydroxyisovaleroyl 
chloride (Peoc-Hyiv-Cl)97 
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Peoc 
 
3.2. Non-urethane protected amino acid chlorides  
Several sulfonyl protecting groups including 2,2,4,6,7-pentamethyldihydrobenzofuran-5-
sulfonyl (Pbf), ortho-nitrobenzenesulfonyl (o-Nbs), benzothiazole-2-sulfonyl (Bts),98 and 5-
methyl-1,3,4-thiadiazole-2-sulfonyl (Ths) have been used to prepare stable amino acid chlorides 
which find utility, particularly when highly reactive coupling agent is required. Sulfonamide 
linkage is completely stable to the conditions employed for both the preparation of acid chlorides 
as well as their use as coupling agents. However their deprotection is quite cumbersome due to 
requirement of harsh conditions. A list of sulfonyl as well as other non-urethane protected amino 
acid chlorides and their properties are compiled in table 3. 
 
Table 3 Non-uretharne protected acid chlorides: Preparation and properties* 
Entry Protecting group Reaction condition Amino acid chloride Remarks  
1 
S
O O
 
       Tos 
(a) SOCl2 in CHCl3 at  
45 oC for 15 min.  
L-Phg (mp = 134-137 oC)99 
D-Phg (mp = 133-136 oC)99  
Phe (mp = 124-126 oC)100 
Cys(SBn) (45.5 %, mp = 
112-114 oC),101 Pro,102 Ala103 
Recrystallized as 
crystalline 
solids.104 
 
(b) PCl5 in dry ether,      
 0 oC to room temperature  
pyroglutamyl chloride (Glp) 
(90%, mp = 71-74 oC)105 
 
S
O O
 
SOCl2 in dry benzene at 
room temperature to 
reflux for 3 h  
Ala103,106  
2 
O2N
S
O O
 
       Nosyl (Ns) 
SOCl2 in CH2Cl2 at reflux 
for 30 min106,107
 
L-Phe, D-Phe, Leu, Ile, Val, 
L-Ala, D-Ala103,106 
Yellowish solids 
obtained in 
quantitative 
yields. 
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3 
S
O O
NO2
 
       o-Nbs 
1-chloro-N,N,2-trimethyl-
1-propenylamine, 
collidine108,109 
Ala   
4 
S
N
S
O O
 
        Bts 
SOCl2 in CH2Cl2 at reflux 
for 2 h110 
Phg, Leu, Val, L-Ala, D-
Ala110,111 
 
5 
N
S
N S
O O
 
         Ths 
SOCl2 in CH2Cl2 at reflux 
for 2 h111 
Phg111  
6 
S
O
O
O
 
           Pbf 
 N-Me-Aib112  
7 
F3C
O
 
        TFA 
(a) Vilsmeier reagent in 
n-BuOAc at -10 to -12 oC 
for 3 h54,113-116 
Phe, Lys54,117 Acid chlorides 
found stable for at 
least 24 h when 
maintained at -10 
oC in EtOAc, 
BuOAc and 
CH2Cl2 whereas in 
DMF significant 
racemization was 
observed.  
 
(b) (COCl)2  in dry 
benzene, pyridine (3 
drops) at reflux for 15 
min54 
Ile, Met, Tyr, Pro54,117 
 
(c) (COCl)2 in CH2Cl2, 
DMF (0.5 mL/0.1 mL) at 
room temperature for       
2 h117 
Pro118 
8 
N
O
N
N
 
SOCl2 in CH2Cl2 at room 
temperature, 24 h or 
reflux for 1 h  
Val, Leu, Phe, D-Phg119-122 
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      Btc 
9 O2N
NO2
 
    2,4-DNP 
SOCl2 at reflux for 1 h  Gly (92.5%, mp = 129-130 
oC), Ala123-125 
Recrystallized 
using benzene as 
crystalline solids. 
10 O
O
 
        Pht 
PCl5 in dry benzene at 50-
55 oC (boiling water bath)  
Ala (93%, mp = 55 oC) 
Phe (87%, mp = 86 oC) 
Phg (85%, yellow oil)126-130 
Gly (mp 84-85 oC)131 
 
11 Tos/phenyl/2-methyl-
5-nitrophenyl/4-
methyl-3-
nitrophenyl/sulphonyl  
SOCl2, reflux, 1 h glutamic acid dichloride132  
*selected amino acid derivatives listed 
3.3. Azido acid chlorides 
Meldal et al. has proposed azido acid chlorides as highly efficient coupling agents with small 
size amino protecting group.133 Several proteinogenic amino acids could be converted into α-
azido acid chlorides with triflylazide (TfN3), followed by treatment with SOCl2. The acid 
chlorides of hindered α-azido acids can be obtained using excess of SOCl2 at 50 oC. Weigelt and 
Sewald reported 2H labeled α-azidoisobutyryl chloride (D6-Aib-Cl) as Aib equivalent building 
block from acetone cyanohydrin-D6 in six steps in good yield (61%) and high degree of 
deuteration for solid phase peptide synthesis (SPPS).134 The percentile deuterium incorporation 
was found to be more than 90 according to NMR and MS data. D6-Aib equivalent can be 
incorporated into peptides for determination of three dimensional structures of peptides.   
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The last, but not the least ones are amino acid chloride hydrochlorides.135-139 An amino 
acid in acetyl chloride on treatment with PCl5 gives amino acid chloride hydrochloride. 
However, they are used sporadically.  
3. 4. β- and γ-Amino acid chlorides 
β- and γ-Amino acid chlorides were also prepared employing reagents SOCl2 and oxalyl chloride 
and most of which have been used as such and not isolated (Table 4). 
 
 
 
Table 4 
Preparation of β- and γ-amino acid chlorides 
Entry Amino acid chloride Reaction condition Remarks  
1 
FmocHN
R
Cl
O
 
R = CH3, CH(CH3)2, CH2CH(CH3)2, 
CH(CH3)CH2CH3 
SOCl2 in CH2Cl2 at 
reflux for 2 h140 
The chemical and optical 
purity of these acid 
chlorides was determined 
spectroscopically after their 
conversion into methyl 
esters. 
2 
 
 
(COCl)2  in dry 
benzene, pyridine 
(three drops) at reflux 
for 15 min141 
Obtained as clear yellow 
liquid. Acid chloride was 
diluted immediately with 
dry CH2Cl2 and used 
without further purification.  
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3 
N Cl
CH3
Ns
O
 
N
CH3
Ns
O
Cl
 
SOCl2 in dry ethanol-
free CHCl3 at reflux 
for 20-30 min107 
 
Obtained in quantitative 
yield as yellowish 
amorphous solids. 
 
 
4. Coupling  
Availability of plethora of coupling protocols tempts the practitioners of peptide 
chemistry to opt for a so called ‘racemization free protocol’. There is a risk of racemization 
associated with acid chlorides as coupling agents unless otherwise two aspects are appropriately 
addressed, (i) nature of Nα-protecting group versus reagent/method used for acid chloride 
formation and (ii) conditions employed for coupling. However, undoubtedly, the acid chlorides 
are the reagents of choice, particularly in the assembly of sterically hindered as well as difficult 
peptide sequences. Their utlity in acylation of weak nucleophilic amines has been found widely 
useful in organic synthesis. 
The aminolysis of the protected amino acid chloride with the desired amine will generate 
an amide bond and HCl is released as the undesired product. Thus it’s essential that the amide 
bond formation be carried out in presence of a base, to trap the hydrogen chloride liberated. 
Otherwise, protonation of amino component by HCl will hamper both the rate of coupling and 
yield of the product significantly. Dry conditions can be employed in presence of a non-
nucleophilic base such as N-methylmorpholine (NMM), triethylamine (TEA), collidine or DIEA 
to trap the HCl.142 This reaction is found to be accelerated by catalytic amount of pyridine or 
DMAP.143 The acyl pyridinium intermediate 33 is proposed for the observed catalytic action 
(Scheme 6).  
 
Scheme 6. Catalytic role of pyridine in amide bond formation via acyl pyridinium salt intermediate. 
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However, the use of base has undesired effect on the conversion, leading to the formation 
of oxazolones, which naturally aminolize at a slower rate. Thus racemization via oxazolone 
formation, premature deprotection of protecting groups in case of base labile protecting groups 
and other side reactions including N-carboxyanhydride formation initially hindered the use of 
protected-amino acid chlorides in peptide coupling. In a strategy to overcome these difficulties, 
two phase system employing 5% NaHCO3/CH2Cl2 or CHCl3 i.e., Schotten-Baumann condition 
has been successfully developed and utilized which minimizes the contact of acid chloride with 
the base.5 In a deviation to conventional solution phase methods, even soild supports such as 
poly-4-vinylpyridine (P4PVy) (copolymer of 4-vinylpyridine with divinylbenzene) have been 
proposed as HCl acceptors.144 In a nutshell, several strategies are envisaged to ensure rapid 
acylation with stability as well as circumvention of oxazolone formation with concomitant loss 
of chirality. 
In other methods, metal and metal oxides have been used to mediate coupling reactions. 
In these reactions, corresponding metal halide is the byproduct. MgO has been employed by 
Katsoyannis and Du Vigneaud in the coupling of tosyl amino acid chlorides with free amino 
acids.145 Though various reports have emerged on metal mediated amide bond formation, their 
application in peptide chemistry is limited. Some of the successful results include the use of zinc 
dust,146 indium,147 and CuO148 mediated peptide coupling.  
Various co-coupling agents/additives such as potassium salts of 1-hydroxybenzotriazole 
and 7-aza-1-hydroxybenzotriazole (KOBt 71a and KOAt 71b respectively) in place of tertiary 
amine have been utilized to circumvent the necessity of use of equimolar quantity of base during 
coupling and thus, instead of HCl, KCl is formed as other product.149,150 The use of 1-(t-
butyldimethylsilyloxy)benzotriazole 72 (TBDMS-OBt), results in the formation of t-
butyldimethylsilyl chloride (TBDMS-Cl) which is completely soluble in organic solvent.151,152  
Another strategy involved the use of N-allyloxycarbonyl (Alloc) amino acid methyl esters 
70, which were sequentially treated with Pd/PhSiH3 and acid chlorides to obtain peptides.153,154 
In all these protocols, peptide bond formation can be achieved in organic solvent without 
necessity of either organic or inorganic base.  
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4.1. Solution phase synthesis 
Several attempts have been made in the earlier stages of peptide synthesis to make use of 
acid chlorides, due to their highly reactive nature. One of the very first attempts by Emil Fischer 
involved demonstration of the feasibility of the use of amino acid chloride hydrochlorides135-138 
as coupling agents with simultaneous carboxyl activation as well as amino protection.139 Ethyl L-
alanylglycinate was obtained by coupling L-alanyl chloride hydrochloride with ethyl 
glycinate.135-138 Several of peptides including L-alanyl-glycine, leucylglycylleucine, 
leucyltriglycine, L-prolyl-L-phenylalanine, L-tryptophylglycine were made albiet with lesser 
purity.88-90,135,155  However in solution, a part of the amino acid chloride hydrochloride undergoes 
deprotonation and the acylation of free amine leads to a mixture of products. 
4.1.1. Schotten-Baumann conditions  
The only activation method compatible to accomplish coupling in water (i.e., Schotten-
Baumann conditions) is the acid chloride method.  As is well known, in general, the acylation of 
amines using acid chlorides has been accomplished employing Schotten-Baumann conditions. 
Emil Fischer demonstrated coupling employing Etoc-amino acid chlorides 35 under Schotten-
Baumann conditions as well as in non-aqueous media.1 In one of these studies, 2 eq of amino 
acid ester 38 was employed, wherein additional equivalent of amino acid ester served as a HCl 
acceptor (Scheme 7). Obviously, the use of an additional molar quantity of amino acid ester is 
not practiced, due to the escalation in the cost of the protocol. 
Scheme 7. Coupling employing Etoc-amino acid chlorides under Schotten-Baumann conditions 
and in non-aqueous media. 
4.1.1.1. Fmoc Chemistry 
Due to the base lability of Fmoc moiety, there is a feasibility of premature deblocking of 
the Fmoc group. Consequently, coupling methods evolved in two pathways involving two phase 
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system with mild inorganic base in aqueous layer to minimize contact with the acid chloride as 
well as in homogeneous solution assisted by a HCl acceptor (Scheme 8).  
               
Scheme 8. Various protocols employed for coupling of Fmoc-amino acid chlorides. 
 It was envisioned by Louis Carpino that Fmoc chemistry and the acid chloride method are 
compatible with each other with simple modifications in coupling conditions without 
racemization156 (Scheme 9). Carpino’s group succeeded in rapid synthesis of short peptide 
segments using Fmoc-amino acid chlorides as coupling agents in biphasic medium.5 The method 
involved a two-phase system consisting of CH2Cl2 or CHCl3 with a mild inorganic base (5% 
Na2CO3 or 10% NaHCO3) in the aqueous layer to minimize contact with the acid chloride. The 
excess acid chloride was scavenged by addition of N-methylpiperazine and deblocking was 
carried out by 4-(aminomethyl)piperidine (4-AMP). A phosphate buffer (pH 5.5) extraction 
ensures the separation of dibenzofulvene (DBF) adduct of 4-AMP 44 (Scheme 9). 
[Leu5]Enkephalin (Tyr-Gly-Gly-Phe-Leu) was synthesized77,157-159 on a ten mmol scale within 4 
h in 50-55% yield and the overall racemization at the Phe residue, was found to be less than 
0.1%, as determined by measuring the ratio of D, L, LL diastereomers of N-methylbenzoyl 
phenylalanylleucinate.  
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AA2-OBn
NaHCO3
CHCl3 : water
4-AMP, CHCl3
N
NH
(removed by extracion
with phosphate buffer)
repeating the steps
with appropriate
Fmoc-AA-Cl
MeOH, 1,4-dioxane
Pd-C/NH4OCHO
Fmoc-AA1-Cl
29
Fmoc-AA1-AA2-OBn H-AA1-AA2-OBn
Fmoc-AA5-AA4-AA3-AA1-AA2-OBn H-AA5-AA4-AA3-AA1-AA2-OH
44
43 45
46 47
 
Scheme 9. Rapid synthesis of short peptide segments using Fmoc-amino acid chlorides in 
biphasic medium. 
 
4.1.1.1.1. Continuous solution phase synthesis 
 Beyermann et al. reported the synthesis of C-terminal tachykinin and N-terminal substance P 
and neurokinin B sequences in an improved protocol employing Fmoc amino acid chlorides.77 
Continuous solution synthesis of peptides in a sequential process up to the heptapeptide stage has 
been carried out, wherein both removal of the excess acid chloride as well as deblocking step 
was accomplished by the use of 4-AMP. DBF adduct of 4-AMP 44 and the byproducts were 
removed by extraction with phosphate buffer (pH 5.5) and the growing peptide chain was 
retained in the organic phase. Using this rapid protocol, a pentapeptide H-Phe-Phe-Gly-Leu-Nle-
NH2 was prepared in 79% overall yield (Scheme 10). In earlier synthesis, the premature 
deblocking of the Fmoc group by N-methylpiperazine and complete extraction of piperazides 
derived from hydrophobic amino acids had lead to around 20-30% yield of the pentapeptide H-
Phe-Phe-Gly-Leu-Nle-NH2. A combination of Fmoc amino acid chlorides and 4-AMP as 
deblocking/scavenging agent has been conveniently employed for the continuous synthesis of 
eight peptides, while corresponding pentafluorophenyl esters were employed wherever required, 
albiet as less reactive substitutes (Table 5). 
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Fmoc-Leu -Cl
Nle-OBn.TsOH
Fmoc-Leu-Nle-OBn +
(excess remains in solution)
+ Base.HCl or NaCl (removed by water wash)
H-Leu-Nle-OBn +
separated by extraction
using a buffer wash
Fmoc-Gly-Leu-Nle-OBn
5% Na2CO3/CHCl3
4-AMP
CHCl3
5% Na2CO3/CHCl3
H-Leu-N
NH2
NHH-Leu-NH-H2C
N
NH
Fmoc-Phe-Phe-Gly-Leu-Nle-OBn
repeated
coupling with
Fmoc-Leu-Cl
Fmoc-Gly-Cl
Fmoc-Phe-Cl
1. deprotection with trifluoroacetic acid (TFA)
2. 15% NH3 in CH3OH
3. 4 N HCl in ethyl acetate (EtOAc)
Phe-Phe-Gly-Leu-Nle-NH2
.HCl
Scheme 10. Continuous solution synthesis of pentapeptide H-Phe-Phe-Gly-Leu-Nle-NH2. 
Table 5 List of peptides synthesized by Fmoc-amino acid chloride/4-AMP coupling-deprotection 
strategy77 
Entry Compound Yield (%) 
1 H-Phe-Phe-Gly-Leu-Nle-NH2.HCl 79 
2 H-Lys(Cbz)-Phe-Phe-Gly-Leu-Met-NH2.2HCl 73 
3 H-Phe-Phe-Val-Gly-Leu-Met-NH2 29 
4 H-δ-Ava-Phe-Phe-Gly-Leu-Nle-NH2 40 
5 Boc-Gln¦-Glu(OBn)-Phe-Phe-Gly-Leu-Nle-OBn 47 
6 H-Lys-Pro-Lys-Pro-NHC12H25.HCl 47 
7 Cbz-Arg(NO2)¦-Pro-Lys(Cbz)-Pro-OH 84 
8 H-Arg-Pro-Lys-Pro¦-δ-Ava-Phe-Phe-Gly-Leu-Nle-NH2 57.6 
* pentafluorophenyl ester (entries 5 & 7) or the mixed anhydride  method (entry 8) was employed at the bond 
indicated by ¦ . 
In a subsequent improvement of continuous solution phase synthesis, 4-AMP was 
replaced with tris(2-aminoethyl)amine (TAEA). The use of TAEA simplified the workup during 
buffer extraction, whereas 4-AMP/DBF adducts lead to the formation of emulsions or precipitate 
with certain sequences in CH2Cl2 as a solvent. Also synthesis can be carried out in monophasic 
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medium in CH2Cl2 as demonstrated by coupling of Fmoc-D-Phg-Cl to H-Phe-OMe·HCl in 
presence of TEA (Table 6).160   
Table 6 List of peptides synthesized by Fmoc-amino acid chloride/TAEA coupling-deprotection 
strategy160 
Entry Peptide  Yield (%) 
1 Fmoc-Gly-Gly-Phe-OBn 69.6 
2 Fmoc-Tyr(Bn)-Gly-Gly-Phe-Leu-OBn 45.8 
3 H-Lys-Pro-Lys-Pro-NH-C12H25 60.9 
4 H-Phe-Phe-Val-Gly-Leu-Met-OBn 40.0 
5 H-Phe-Phe-Val-Gly-Leu-Met-NH2 32.4 
 
4.1.1.2. Other protecting groups 
Bspoc amino acid chlorides were employed in two phase using CH2Cl2/H2O/NaHCO3 
system and silica tethered secondary amine 4-aminomethyl piperidine (4-AMP) silica as 
deblocking agent (Table 7). The high reactivity (high acylating activity) of acid chloride 
diminishes the attack of amine donor at the second electrophilic center, the Michael acceptor. 
The protocol was illustrated with efficient synthesis of Fmoc-NH-[Leu5]enkephalin in a 
continuous solution assembly without isolation of any of the intermediates (with exception of 
Fmoc-Tyr(Bn)-Cl for the final coupling step) in overall yield of 30%.85  
Table 7 List of peptides prepared through other urethane protected amino acid chlorides 
 
 
 
Poc amino acid chlorides were employed as coupling reagents employing H2O-Na2CO3 (6 
eq)-CH2Cl2 system at -5 to 0 oC to assemble few Poc protected dipeptides in solution phase 
within 15 min in high yields as crystalline solids.86 The peptides were found to be 
diastereomerically pure as determined by the use of chiral shift reagent in 1H NMR as well as 
chiral HPLC. 
Entry Peptide Yield (%) 
1 Bspoc-Phe-Phe-OtBu 94.3 
2 Bspoc-Phe-Phe-Phe-OtBu 75 
3 Poc-Ala-Ala-OCH3 83 
4 Poc-Phe-Phe-OCH3 88 
5 Poc-Phg-Phg-OCH3 86 
6 Poc-Phg-Phe-OCH3 88 
7 Poc-Phg-Ala-OCH3 83 
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             Vedejs group claimed Bts and Ths amino acid chlorides as practical reagents for difficult 
solution phase couplings and other applications wherein the high reactivity of acid chloride is 
desirable (Fig. 2). Thus Bts and Ths protected amino acid chlorides110,111 were reported for 
peptide coupling reactions including the ones involving sensitive phenylglycine (Phg) residues as 
well as hindered amino acids in the absence of any organic additive with the ease of product 
purification involving no chromatography or crystallisation. In this study Bts-Phg-Cl was 
coupled to amino acid esters (Ala-OCH3, Phe-OtBu, Aib-OCH3) in bi-phasic medium (aqueous 
Na2CO3/NaHCO3 and CH2Cl2; 0-5 oC; 15 min) and products were isolated in high yields. The 
diastereomeric purity of peptides 48 was satisfactory with a maximum of 0.1% racemization of 
the Phg (phenylglycine) subunit (≥ 99.8% retention). Deprotection of diastereomers using 
inexpensive reagents zinc/AcOH-EtOH or 50% H3PO2 resulted in peptides with no change in 
diastereomeric ratio.
 
Also Ths-Phg was utilized via acid chloride coupling yielding peptides 49 
with similar results. Thus Ths-Phg-Phe-OC(CH3)3 and Ths-Phe-Ala-OCH3 were prepared in ≥ 
99.8% de.  
S
N
H
H
N
O
COOY
a. R1 = CH3; Y = CH3 (yield = 95%)
b. R1 = Bn; Y = tBu (yield = 92%)
R1
N
S
O O
S
N
H
R H
N
O
COOX
c. R = Ph; R1 = Bn; X = C(CH3)3 (yield = 78%)
d. R = Bn, R1 = CH3, X = CH3 (yield = 61%)
R1
S
N N
O O
48 49
S
N
H
H
N
O
COOMe
(yield = 87%)
N
S
O O
N
H
H
N
O
COOMe
(yield = 65%)
S
O O
N
N
S
S
N
H
H
N
O
COOMe
(yield = 91%)
N
S
O O
50 51 52
 
Figure 2. Dipeptides prepared using Bts and Ths amino acid chlorides. 
  Nosyl amino acid chlorides have been successfully employed in solution phase synthesis 
of peptides using aqueous NaHCO3/CHCl3 system and found to be compatible with side chain 
protecting groups used in Fmoc-based strategy (Fig. 3). Nosyl-protected peptides 53 and 54 
could be obtained in high yields and purity at room temperature within 1 h.  
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Racemization study by GC/MS and 1H NMR analyses of diastereomers Ns-L-Phe-L-Ala-OMe 
and Ns-L-Phe-L-Ala-OMe confirmed the absence of epimerization.161,162 
 
Figure 3. Dipeptides synthesized from Nosyl amino acid chlorides. 
  Nosyl amino acid chlorides 56 were also coupled with the dipeptide esters 57 and N-
methylated dipeptide ester to yield tripeptides 58 and few hindered oligopeptides in high yield 
with no contamination by epimers as established by 1H NMR studies of diastereomeric peptides. 
The coupling conditions were compatible with acid labile side chain protecting groups which 
was demonstrated by coupling of Nosyl-amino acid chlorides 56 with dipeptide methyl esters 
containing acid labile side chain protecting groups to yield corresponding tripeptides in good 
yields of 71-85% (Scheme 11; Table 8).106,163 
N
H
O
H
N COOMe
O
R4
NsNH
R3
R2 R1
NsNH
R4
Cl
O
+ H2N
O
H
N COOMe
R3
R2 R1
NaHCO3
CHCl3, rt, 1 h
NsNH
O
H
N COOMe
R3
R2 R1
HSCH2COOH/NaOCH3
MeOH, CH3CN, reflux
yield = 71-89%
57 58
55
56
 
Scheme 11. Coupling of Nosyl amino acid chlorides 56 with dipeptide esters. 
Table 8 List of tripeptides prepared through Ns-protected amino acid chlorides106,163 
Entry R1 R2 R3 R4 Yield (%) 
1 CH(CH3)2 H CH3 CH(CH3)CH2CH3 89 
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  Ns-N-Methyl-β3-amino acid chlorides were also treated with aqueous 10% 
NaHCO3/CHCl3 solution of α-amino acid methyl ester hydrochloride at room temperature and 
corresponding products 59 and 60 were obtained in 64-75% overall yields in about 25-30 min 
(Fig. 4).107 
N N
HCH3
Ns
(yield = 75%) (yield = 64%)
O
COOMe N N
HCH3
Ns
O
COOMe
59 60
   
Figure 4. Dipeptides prepared from Ns-N-methyl-β3-amino acid chlorides. 
Jass et al. studied in detail the use of trifluoroacetyl (TFA) amino acid chlorides in 
peptide coupling.54 Herein the Vilsmeir reagent was employed at temperatures below -10 oC and 
the acid chlorides were directly employed in subsequent coupling reactions under Schotten-
Baumann conditions at low temperatures in conjunction with excellent agitation and pH control 
resulting in peptides with high retention of stereochemistry (Table 9). Various TFA protected 
amino acid chlorides were coupled to H-Phe-OMe in good yields and the diastereomeric 
products were found to be < 0.2% by HPLC or GC. An aqueous buffer (K2HPO4) was used to 
maintain the pH in the aqueous layer, and pH was maintained throughout the addition of acid 
chloride by simultaneous addition of aqueous NaOH. Alternatively large excess of aqueous 10% 
NaHCO3 could be used as buffer to the aqueous phase. However TFA-Pro-Phe-OMe was 
obtained in as low as 44% yield which was attributed to side reactions.  
Table 9 List of TFA protected peptides prepared54 
TFA-Protected peptide Yield (%) 
TFA-Met-Phe-OMe 92 
TFA-Ile-Phe-OMe 98 
TFA-Phe-Phe-OMe 91 
TFA-Leu-Phe-OMe 95 
2 H CH(CH3)2 CH3 CH(CH3)CH2CH3 84 
3 H CH3 (CH2)4NH(Boc) CH(CH3)2 85 
4 H CH(CH3)2 CH2C6H4O(tBu) CH(CH3)CH2CH3 75 
5 H CH3 CH2S(Trt) CH(CH3)2 71 
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Nα,Nε-Bis(TFA)-Lys-Phe-OMe 89 
TFA-Tyr-Phe-OMe 98 
 
Extending the protocol, in a synthesis of anti-hypertensive agent vanlev 65, the key 
intermediate 64 was prepared in high yield (> 99 %) and purity at > 100 kg input scale by 
employing acid chloride activation of TFA protected diacid as illustrtated in scheme 12.54 
 
Scheme 12. Synthesis of anti-hypertensive agent vanlev 65. 
4.1.2. Non Schotten-Baumann conditions 
4.1.2.1. Use of co-coupling agents 
As delineated previously, Fmoc amino acid chlorides 29 act as rapid acylating agents in 
biphasic system. However the use of organic bases like DIEA, NMM or pyridine in 
homogeneous solution lead to the formation of corresponding oxazolone 66 with which coupling 
reaction become sluggish. Another concern is the premature deblocking of Fmoc group.164 To 
circumvent these side reactions, the concept of co-coupling reagents was introduced which 
avoids the use of an organic base. KOBt 71a, was applied by Sivanandaiah et al. (Scheme 13) in 
acid chloride chemistry.165 KOBt reacts with HCl, as well as with hydrochloride salt of the 
amino component to ensure both rapid and complete coupling.166 As a base does not mediate the 
coupling, 5(4H)-oxazolone  66 formation is circumvented.76,149,150,167 The undesired product, KCl 
is formed out as a solid which is removed by filtration. Similarly, a combination of Fmoc-amino 
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acid chloride/KOAt 71b has also been utilized successfully. This protocol, similar to that of 
KOBt, is also operationally simple and peptides were obtained in good yields.168                                
FmocHN
Cl
O
HClDIEA
N
O
O
FmO
FmocHN
OBt
O
HOBt
FmocHN
H
N
O
COOMe
H-Leu-OMe
H-Leu-OMe
DIEA
FmocHN
H
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O
COOMe
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H-Leu-OMe
DIEA
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OBt
O
DIEA, HOBt
H-Leu-OMe
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H-Val-OMe
KOBt
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HCl.
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HCl.
.
HCl.
66
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70
 
Scheme 13. Coupling of Fmoc-amino acid chlorides using co-couping agents under non Scotten-
Baumann conditions. 
Further improvement in no base coupling was demonstrated by the use of TBDMS-OBt 
72.151 The reagent 72 can be easily prepared by reacting TBDMS-Cl with HOBt and is stable at 
room temperature for longer periods. Instead of KCl, it results in TBDMS-Cl as other product, 
which is soluble in organic solvent and thus a solvent wash ensures its separation from the 
product (Scheme 14).  
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Scheme 14. Coupling of Fmoc-amino acid chlorides using KOBt and TBDMSOBt. 
4.1.2.2. Metal/metal salts mediated coupling 
Metal mediated acid chloride coupling has been investigated with some encouraging 
results.145 
4.1.2.2.1. Coupling mediated by commercial zinc dust 
Gopi and Sureshbabu employed activated commercial zinc dust as a simple alternative to 
KOBt/KOAt route (Scheme 15; thus in absence of any inorganic/organic base).146 The reaction 
can be carried out in organic solvent such as THF, toluene and found to be free from 
racemization and other side reactions. The noteworthy point of this study is that the 
deprotonation of amino acid methyl ester hydrochloride salts 41 can be concomitantly carried 
out. Thus the use of 2 eq of zinc leads to deprotonation of amino acid ester hydrochloride salt 41 
thereby ensuring the efficient coupling whereas another half acts as HCl acceptor. The ZnCl2 
formed can be removed completely through filtration before workup of the reaction mixture 
(Scheme 16).  
 
Scheme 15. Zinc dust mediated coupling of Fmoc-amino acid chlorides. 
  The mechanism for the zinc dust mediated acid chloride coupling can be illustrated as 
detailed in Scheme 16.169 
 
Scheme 16. Plausible mechanism for the zinc dust mediated acid chloride coupling. 
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     The use of samarium iodide (SmI2) in reactions of Fmoc-Pro-Cl with carbonyl compounds 
was tried but with limited success with respect to stereo control.170 
 
4.1.2.2.2. Microwaves enhanced coupling in the presence of zinc dust 
Microwave  assisted coupling is paramount in peptide chemistry as well.171-185 Tantry et 
al. demonstrated microwave assisted peptide coupling in the presence of zinc dust or BDMS-
OBt 69 for rapid and efficient coupling of peptides.186 Both 1H NMR and HPLC analyses of 
diastereomers, Fmoc-L-Phe-Ala-OMe and Fmoc-D-Phe-Ala-OMe showed the absence of 
racemization during the coupling reaction. Employing a rapid deprotection condition using 
TAEA, assembly of Fmoc-Val-Pro-Gly-Val-Gly-OBn, a repeating pentapeptide fragment of the 
protein elastin could be achieved in 67% yield. 
Jang’s group reported indium metal mediated efficient synthesis of amides from 
corresponding acyl chlorides. Indium mediated reaction of Fmoc-amino acid chlorides lead to 
peptides in good yields of 75-88% in about 6-10 h at room temperature (Table 10).147 No 
epimerization or deblocking of Fmoc-group observed based on both 1H NMR and HPLC 
analysis of reaction mixture. Also Fmoc-amino acid chlorides in presence of catalytic CuO 
coupled efficiently with amino acid esters in 5-6 h at room temperature.148 However only two 
examples were illustrated, viz., Fmoc-Ala-Leu-OMe, Fmoc-Phg-Phe-OMe in 83-85% yields 
(Table 10). Reaction was aclaimed racemization free by 1H NMR analysis and no premature 
deblocking of Nα-protecting group was reported.  
 
Table 10 List of peptides prepared employing metal catalysts147,148 
 
 
 
 
 
 
 
 
                                   
                   Coupling condition: Fmoc-AA-Cl, amino ester, metal catalyst, CH3CN, room temperature 
Entry Peptide Metal catalyst Reaction 
duration 
Yield (%) 
1 Fmoc-Ala-Leu-OMe In 6 h 81 
Cuo 5 h 83 
2 Fmoc-Phg-Phe-OMe In 10 h 85 
Cuo 6 h 85 
3 Fmoc-D-Phg-Phe-OMe In 9 h 88 
4 Fmoc-Phe-Leu-OMe In 9 h 85 
5 Fmoc-Pro-Pro-OMe In 12 h 75 
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In another protocol, Alloc amino acid methyl esters 73 were sequentially treated with cat. 
Pd(PPh3)4/PhSiH3 (10 min) and acylating agent Fmoc-amino acid chloride 29.153 Thus non 
Schotten-Baumann condition during acid chloride coupling could be achieved. Although not 
fully established, the reaction pathway presumed to involve the formation of silyl carbamate 
(Scheme 17).  
 
Scheme 17. Coupling of Fmoc-amino acid chlorides with Alloc amino acid methyl esters using cat. 
Pd(PPh3)4/PhSiH3. 
4.1.3. Coupling involving Cbz- and Boc-chemistry 
Bergmann et al. employed Cbz-amino acid chlorides in several of their syntheses owing 
to their compatibility with the amide bond formation.187 However inherent drawbacks such as 
limited shelf stability and decomposition to the corresponding NCAs sidelined their utility by 
1950s. Thus it is not unreasonable that there are very limited reports describing the use of Cbz-
amino acid chlorides. However in the later years, attempts have been made to obtain Cbz-amino 
acid chlorides in situ at low temperatures and use immediately for coupling without isolation. 
Thus Cbz-amino acid chlorides, though unstable due to their rapid conversion into 
oxazolidinones, have been employed occasionally as intermediates in several acylations. 
  In 1985, Miyazawa et al. reported coupling of Cbz-Phe-Cl 74 to amino group of N-
carboxymethyl amino acid i.e., to H-Cm(OtBu)Val-OEt 75 (Cm = carboxymethyl) at 0 oC in 
84% yield. In the same report, Cbz-Phe-Cl was coupled to H-Cm(Pro-OtBu)-Val-OEt 76 in 77% 
yield (Scheme 18).188 
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CbzHN Cl
O
N
OEt
O
H
ROC
+ CbzHN
N
O
COR
COOEtTEA
THF, 0 oC
R = OtBu (yield = 84%), Pro-OtBu (yield = 77%)74 75
76
 
Scheme 18. Coupling of Cbz-Phe-Cl to amino group of H-Cm(OtBu)Val-OEt 75. 
 
Rapid synthesis of thyrotropin releasing hormone (TRH) by Cbz chemistry was 
demonstrated employing DCHA salts of Cbz-protected amino acids 77 in the presence of SOCl2-
pyridine in overall yield of 76% (Scheme 19).69 Coupling of Cbz-L-Leu.DCHA with Gly-
OEt.HCl in SOCl2-pyridine/CH2Cl2 was found racemization free by both 1H NMR as well as 
Young’s test. However in the synthesis of TRH, 6% of racemized Cbz-D-His(CH2Ph)-L-Pro-NH2 
was obtained during coupling of Cbz-L-His(CH2Ph)-OH.DCHA and L-Pro-NH2.  
 
Scheme 19. Coupling via Cbz-amino acid chlorides starting from DCHA salts of Cbz-amino 
acids. 
In an improved protocol, Cbz-amino acid chlorides 78 generated in situ using 1-chloro-
N,N-2-trimethyl-1-propen-1-amine 8 were coupled with amino acid esters 41 and α-hydroxy 
esters 82 in presence of a base using either pyridine or collidine in the same vessel189 (Scheme 
20). The coupling was carried out in organic phase (CH2Cl2) or biphasic solution of aqueous 
NaHCO3 and 1,4-dioxane. The racemization test on Cbz-L-Ala-L or D-Pro-OBn and Cbz-L-Phe-
L-Ala-OBn by HPLC analysis revealed absence of diastereomers (Scheme 21).189 In another 
report, Cbz-Val-Cl prepared in situ was coupled with tert-butoxycarbonylhydrazone 87, followed 
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by ring closure in trifluoroacetic acid to furnish the Cbz-Val-tetrahydropyridazine-3-carboxylic 
acid ester  89 (Scheme 22). 
  
Scheme 20. Coupling via Cbz-amino acid chlorides 78 generated in situ using 1-chloro-N,N-2-
trimethyl-1-propen-1-amine 8. 
CbzN Cl
O
+
HN
O
O
O
COOH
NHBoc
aq. NaHCO3
1,4-dioxane
N
O
O
O
COOH
NHBocO
CbzN
84
85
86
 
Scheme 21. Coupling of Cbz-Pro-Cl under Schotten-Baumann condition. 
 
O
O CO2Et
NHHN
Boc
Cbz-Val-Cl, CH2Cl2
0 oC to rt, 14 h
CbzHN N
O
HN Boc
CO2Et
O
O CF3CO2H
   rt, 1 h
CbzHN N
O
N
CO2Et
(S,S)+(S,R)(S,S)+(S,R)87
88 89
 
Scheme 22. Coupling of Cbz-Val-Cl to tert-butoxycarbonylhydrazone 87. 
  Rodriguez et al.144 employed linear poly-4-vinylpyridine (P4VPy) 93 as solid phase 
hydrochloric acid acceptor for the synthesis of benzamides and peptides. Cbz-Ala-Trp-OMe 92 
was obtained in 75% yield by pyridinium catalyzed acyl transfer employing Cbz-Ala-Cl 90 in 
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presence of excess of P4VPy. However, formation of Boc-alanyl chloride and subsequent 
coupling in the presence of P4VPy was not satisfactory and Boc-Ala-Trp-OMe was obtained as 
oil in merely 12% yield (Scheme 23). 
 
PgNH
R
Cl
O
N
PgNH
R
N
OCl
NuH
PgNH
R
Nu
O
+
N
HCl
93
2
94 95
 
Scheme 23. Synthesis of peptides from Cbz-amino acid chlorides using linear poly-4-
vinylpyridine (P4VPy) 93 as solid phase hydrochloric acid acceptor.  
Haridasan et al. developed polymer-supported mixed carboxylic dithiocarbamic 
anhydrides as reusable solid phase acylating agents by reaction of acid chlorides with sodium 
dithiocarbamate resins (Scheme 24). The resulting resins were prepared from cross linked 
poly(chloromethylstyrene) (Merrifield resin). Thus, NBOC-Phe-Cl 96 (NBOC = 2-
nitrobenzyloxycarbonyl) was reacted with sodium dithiocarbamate resin 97, to obtain N-
protected aminoacyl dithiocarbamic anhydride 98, which was then treated with a solution of 
ethyl glycinate hydrochloride in presence of TEA, to afford the dipeptide NBOC-Phe-Gly-OEt 
99.190 
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Scheme 24. Polymer-supported mixed carboxylic dithiocarbamic anhydrides as reusable solid 
phase acylating agents. 
Hardee et al. developed an efficient aromatic cation activation method for rapid 
generation of acid chlorides in the presence of an amine (Scheme 25).55 The protocol was mild 
enough to accommodate substrates with acid-sensitive functionalities such as glycol acetal, silyl 
ether, etc. and peptide coupling involving Boc amino acids was carried out on a preparatory 
scale. Boc amino acids 100 were reacted with 3,3-dichloro-1,2-dimesitylcyclopropene 10 
(generated in situ from 2,3-dimesitylcyclopropenone and oxalyl chloride or can be used after 
isolation as well) and DIEA,  which was then treated with amino acid ester. Thus two peptides 
were synthesized on gram scale without loss of any stereochemical integrity. Boc-Ala-Phe-OCH3 
was obtained in 80% yield (1.13 g, > 20:1 dr) at 23 oC in 5 min. For racemization prone Boc-
Phg, reaction was carried out at -78 oC and Boc-Phg-Phe-OCH3 was isolated in 77% yield (1.28 
g, > 20:1 dr) in 20 min. 
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Scheme 25. Coupling of in situ generated Boc-amino acid chlorides using 3,3-dichloro-1,2-
dimesitylcyclopropene 10. 
Fuse et al. employed BTC in rapid and efficient activation of carboxylic acids in 
microflow reactor for the continuous-flow synthesis of amides (44-95% yield) and peptides 
(74%-quantitative yield) without significant epimerization (≤ 3%).191a,b Ley and coworkers 
developed a machine-assisted flow synthesis of meclinertant (SR48692), a neurotensin receptor 
antagonist wherein similar strategy was employed for the coupling of an intermediate pyrazole 3-
carboxylic acid to tert-butyl ester of adamantane amino acid using in situ generated phosgene.191c 
Herein a FlowIRTM inline infrared spectrometer was employed to monitor the formation of acid 
chloride i.e., disappearance of the phosgene stretch at 803 cm-1 allowed an injection of a 
matching solution of the amino acid ester. 
In another report, modified Wang resin supported cyanuric chloride 12 has been 
developed for conversion of Boc-Phe-OH 103 to Boc-Phe-NHCH2Ph 105 albeit with complete 
racemization (Scheme 26).56 
 
Scheme 26. Coupling of in situ generated Boc-amino acid chloride using modified Wang resin 
supported cyanuric chloride. 
4.1.4. Coupling involving other protecting groups 
4.1.4.1. Peoc chemistry 
Reactivity of Peoc-amino acid chlorides was explored in racemization free synthesis of 
sporidesmolic acid B (H-Hyiv-Val-MeLeu-OH, Hyiv = α-hydroxyisovaleric acid) by Kunz’s 
group.192 Sterically demanding amide couplings were achieved satisfactorily by employing stable 
Peoc protected acid chlorides of the amino and hydroxy acids in presence of pyridine at room 
temperature. Herein sporidesmolic acid B was accomplished with no racemization despite two 
fold activation and condensation involved. In another report, synthesis of all L-configurated 
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cyclohexadepsipeptide cyclo-[L-Val-L-Lac]3 106 has been achieved using the Peoc/acid chloride 
method (Scheme 27).193 
 
Scheme 27. Synthesis of cyclohexadepsipeptide cyclo-[L-Val-L-Lac]3 106 using Peoc-amino 
acid chlorides. 
4.1.4.2. Tosyl chemistry 
It is known that even under mild alkaline conditions, α-tosylamino acid chlorides 107 
undergo decomposition to yield tosylamide 108, CO, and an aldehyde (Scheme 28). However at 
the pH of an aqueous MgO suspension194 successful acylation can be carried out using α-
tosylamino acid chlorides, wherein rate of decomposition becomes slow enough to permit 
acylation.195,196  
TosHN
R
Cl
O
OH-
TosN
R
Cl
O
-Cl-
TosN
R
O
-CO
TosN R
RCHO
 H2O Tos-NH2
107
108
  
Scheme 28. Decomposition α-tosylamino acid chlorides 107 to tosylamide under mild alkaline 
condition. 
Katsoyannis and Du Vigneaud employed Tos-L-Ile-Cl 109 in presence of aqueous MgO 
above pH 8.0 in the synthesis of Tos-L-Ile-L-Gln-OH 110 and Tos-L-Ile-L-Gln-L-Asn-OH 111 
(Scheme 29).145 The chemistry was extended to Tos-L-Ile-L-Leu-OH and Tos-L-Ile-L-Gly-OH 
assembly as well. Similar protocol was employed for the preparation of glutamyl-asparagine by 
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using l-tosylpyroglutamyl chloride.105,197 In addition, Tos-L-Phe-L-Gln-L-Asn-OH was obtained 
by treatment of the magnesium salt of L-Gln-L-Asn-OH in aqueous solution with Tos-L-Phe-Cl 
in presence of excess MgO.100 
 
Scheme 29. Coupling of Tos-amino acid chlorides using MgO. 
 
  Tos-Phg-Cl and Tos-D-Phg-Cl were utilized in the synthesis of a set of diastereomers 
Tos-Phg-Ala-OMe and Tos-D-Phg-Ala-OMe.99 
Berse et al. obtained protected dipeptides 112 containing cysteine, glycine, phenylalanine 
and tyrosine by employing tosyl amino acid chlorides with amino acid benzyl or ethyl esters.101 
As observed previously, tosyl protected amino acid chlorides were found efficient as the mixed 
anhydride method failed to result in any coupling product (Table 11).  
Table 11 List of dipeptides using Tos-amino acid chlorides 
N
H
R H
N
O
S
O
O
COOBn
R1
112
 
Entry R R1 Yield (%) 
1 CH2S(Bn) H 60 
2 CH2S(Bn) CH2C6H5 70 
 
4.1.4.3. Phthaloyl chemistry 
 
Phthaloyl protection was employed by Sheehan et al. in the synthesis of several 
stereochemically pure peptide derivatives.198 Pht-Phe-Cl was prepared by reacting Pht-Phe and 
PCl5 in dry benzene at 50-55 oC for 1 h. Then it was reacted with glycyl anilide hydrochloride to 
obtain phthaloyl-L-phenylalanylglycyl anilide. Methyl phthaloyl-glycylglycinate (yield = 90%, 
mp = 203-204 oC) and ethyl phthaloyl-L-phenylalanylglycinate (yield = 59%, mp = 160-161.5 
oC) were also prepared in good yields.198-200  
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4.2. Solid phase peptide synthesis 
The acid chlorides as coupling agents failed to come good in case of solid phase peptide 
synthesis (SPPS) due to their sluggish reactivity.  Infrared studies on model acylating reactant 
Fmoc-Val-Cl 66 upon addition of DIEA or NMM, revealed that a competing oxazolone 67 
formation (Scheme 30) accelerated by the tertiary amine has driven this sluggishness.201-205 It 
was reasoned that lesser reactivity of the polymer-bound amine compared to its counterpart in 
solution has lead to the formation of oxazolone.  
                                                               
Scheme 30. Oxazolone formation during coupling of Fmoc-amino acid chlorides and the use of 
HOBt to avoid in situ oxazolone formation. 
In studies carried out by Carpino et al. upon addition of methyl leucinate hydrochloride 
salt to a solution of Fmoc-valine derived oxazolone in CH2Cl2, initial rapid reaction levels to the 
formation of a mixture comprising 50% Fmoc-Val-Leu-OMe, 50% Fmoc-Val-Cl and 50% H-
Leu-OMe.HCl.206-208 Consequently, a 1 : 1 mixture of organic base-HOBt as promoter for rapid 
coupling reaction between Fmoc amino acid chlorides and resin bound amino acids was initially 
tried.208 Infrared studies confirmed that Fmoc amino acid chlorides get rapidly converted to the 
corresponding HOBt ester, which mediated the reaction leading to efficient acylation process. 
Thus under HOBt/DIEA conditions 97.3% coupling occurred within 1 min. The HOBt anion is 
the active catalytic species, generated by the reaction of the added HOBt and the resin bound 
amino acid. There was no premature deblocking of Fmoc moiety of Fmoc-Leu-Pepsyn KA 
(Pepsyn KA, kieselguhr supported polyacrylamide resin) up to 4 h. Racemization studies 
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in the coupling of Fmoc-Phe-Cl with H-Leu-Pepsyn KA under 1 : 1 HOBt/DIEA conditions, as 
analysed by RP-HPLC, showed less than 0.1% of the DL diastereomer. 
Synthesis of [Leu5]enkephalin was carried out on a one gram scale of Pepsyn KA resin 
loaded with 0.1 milli eq/g of Fmoc-Leu using 5 eq of acid chloride (0.1 M in DMF) and the 
binary mixture of HOBt/DIEA in DMF solution. The acylation duration was 10 min. After 
completion of the assembly of sequence, the acylated resin was treated with TFA (2 h), to afford 
the TFA salt of the crude peptide (69%, approximately 93% pure). No significant racemization 
(< 0.1% of the D-Phe diastereomer) was observed by GC analysis of the hydrolysed pentapeptide 
on a chiral column. Similarly, acyl carrier protein (ACP) decapeptide 65-74 fragment (H-Val-
Gln-Ala-Ala-Ile-Asp-Tyr-Ile-Asn-Gly-OH), prothrombin (1-9), substance P analog (H-Lys-Pro-
Lys-Pro-Gly-Gly-Phe-Phe-Gly-leu-Nle-NH2) and eledoisin were assembled in solid phase 
successfully while substituting the pentafluoro or other stable esters for amino acids bearing tert-
butyl protected side chains.208 
A combination of HOBt/DIEA proved most efficient as both catalyst and HCl acceptor 
when compared to others including HOBt/TEA, HOOBt/DIEA (study involved Fmoc-Val-Cl + 
H-Leu-Pepsyn-KA or Fmoc-Phe-Cl + H-Phe-Gly-OCH2CO-BHA; BHA = benzhydrylamine 
resin), other N-hydroxy compounds N-hydroxysuccinimide (HONSu), N-hydroxyphthalimide in 
combination with DIEA (Fmoc-Phe-Cl + H-Leu-Pepsyn-KA).  HOBt/DIEA also catalyzes the 
aminolysis of Fmoc amino acid pentafluorophenyl esters (OPfp), however Fmoc-Asn-OPfp and 
Fmoc-Gln-OPfp rapidly decomposed in solutions of HOBt/DIEA in DMF.208 
The study also revealed that Fmoc amino acid chlorides and pentafluorophenyl esters 
compared to benzotriazol-1-yloxytris(dimethyl-amino)-phosphonium hexafluorophosphate 
(BOP) and O-benzotriazol-1-yl-1,1,3,3-tetramethyluroniumtetrafluoroborate (TBTU) mediated 
couplings, gave the highest Fmoc-Val incorporation. Thus several short and medium sized 
peptides [Leu5]enkephalin, substance P analogs, ACP 65-74 fragment, prothrombin (1-9) were 
assembled using both polystyrene and polyacrylamide resins.209  
 
5. Assembly of sterically hindered peptides 
High reactivity of acid chlorides has been adopted for introducing sterically hindered 
amino acids into peptide sequences, which otherwise have shown inferior results by most of the 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
44 
 
conventional methods. Several protocols have been developed for the assembly of peptides 
containing hindered amino acids through acid chloride method in both solution as well as solid 
phase.203,204  
N-Acetyl oxazolone derivatives of Ser and Thr have been converted to highly reactive acid 
chlorides, and the crude acid chlorides 114 and 116 are utilized efficiently with a variety of 
nucleophiles, particularly notoriously unreactive ones such as pipecolinate esters (Scheme 31).210  
H2N COOH
CH2OH
(a) - (d)
O N
O O
COCl
H
(a) COCl2, NaOH, K2CO3, H2O, 25
oC
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(d) 10% Pd/C, MeOH, 25 oC
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Scheme 31. Coupling of acid chlorides prepared from N-acetyl oxazolone derivatives of Ser and 
Thr. 
5.1. Coupling mediated by AgCN  
Takimoto et al. reported preparation of sterically hindered esters from the corresponding 
acyl chlorides and alcohols mediated by AgCN.211,212 The reaction seems to proceed with the aid 
of electrophilic catalysis of Ag+ ion. Similar protocol was then adopted for peptide bond 
formation including hindered amino acids, as it was found to accelerate the rate of coupling 
leading to an increase in the yields.  
5.1.1. Cyclic hexapeptides: Oxytocin antagonists 
Perlow et al. reported SPPS of cyclic hexapeptide oxytocin antagonists [analogs of L-
365,209 (117)] cyclo-(D-Phe-Ile-D-Pip-Pip-D-(N-Me)Phe-Pro) (118), L-366,682 (119) and L-
366,948 (120) (Fig. 5).213 The antagonist cyclo-(D-Phe-Ile-D-Pip-Pip-D-(N-Me)Phe-Pro) (118) 
was synthesized in 70% yield starting from Boc-L-Pro-O-PAM-resin [PAM = 4-
(hydroxymethyl)phenylacetamidomethyl poly(styrene-codivinylbenzene) resin]. The high 
reactivity of Fmoc-L-pipecolic acid chloride used in the di- to tripeptide step averted the 
diketopiperazine formation usually observed with active ester couplings (Scheme 32). Further L-
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366,682 (119) and L-366,948 (120), two potent and selective antagonists were made in 45-48% 
overall yield on a twenty mmol scale.  
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Figure 5. Cyclic hexapeptide oxytocin antagonists [analogs of L-365,209 (117)]. 
 
Scheme 32. Synthesis of oxytocin antagonist cyclo-(D-Phe-Ile-D-Pip-Pip-D-(N-Me)Phe-Pro) 
118. 
In a synthesis of another analog of oxytocin antagonist cyclo-(D-Phe-Ile-D-∆-Piz-Pip-D-
His-Pro) (122, ∆-Piz = dehydropiperazic acid), the acylation of sterically hindered Nδ-Cbz-
piperazic acid N-terminus with Fmoc-L-isoleucine was found to be cumbersome. Only 30% yield 
could be obtained even when excess Fmoc-L-Ile-Cl was used in the presence of DIEA.214 A 
modification of coupling protocol with 4 eq AgCN in toluene at 80 oC, lead to improved 
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conversion up to 76% with one treatment and 96% conversion could be achieved with two 
treatments (Scheme 33).  
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Scheme 33. Synthesis of oxytocin antagonist cyclo-(D-Phe-Ile-D-∆-Piz-Pip-D-His-Pro) 122. 
Although the mechanistic aspects of coupling is not completely understood, an activated 
form of the isoleucine 2-alkoxy-5(4H)-oxazolone derivative 124 was proposed as an 
intermediate under these conditions (Scheme 34).213 
 
Scheme 34. AgCN mediated formation of 2-alkoxy-5(4H)-oxazolone derivative 124 from Fmoc-
Ile-Cl. 
 
5.2. Coupling of acid chlorides to N-silylated amino esters  
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N-Silylamines215-217 have been prominent class of nitrogen nucleophiles, by virtue of 
increased nucleophilicity of nitrogen on account of silylation.218,219 The N-trimethylsilylamines 
or lactam derivatives have been synthesized using trimethylchlorosilane (TMS-Cl) and 
equimolar quantity of a tertiary base to trap HCl.220,221 Alternatively,  N,O-
bis(trimethylsilyl)acetamide (BSA) has been employed for silylation of amines whenever the use 
of organic base need to be avoided.222,223 It acts as a non basic acid scavenger and thus avoids 
premature deprotection.  
Williams et al.224 reported the synthesis of sterically hindered dipeptide fragment Fmoc-
Ile-D-∆-Piz wherein Fmoc-Ile-Cl was coupled to D-(Nδ-Cbz)Piz 125 using TMS-Cl in presence 
of DIEA (Scheme 35). This approach was employed for the incorporation of oxidation sensitive 
functionality in the cyclic hexapeptide oxytocin antagonists derived from streptomyces silvensis 
(known as L-365,209) using fragment coupling strategy. 
Scheme 35. Synthesis of sterically hindered dipeptide fragment Fmoc-Ile-D-∆-Piz from Fmoc-
Ile-Cl. 
BSA was employed for the silylation of amino acid esters to demonstrate its utility 
particularly in the incorporation of sterically hindered amino acids into peptide sequences.223 The 
N-silylation of amino component during peptide coupling was further fine-tuned by Sureshbabu 
et al. using TMS-Cl and zinc dust under no base conditions.225 Amino acid methyl ester 
hydrochloride salt was initially deprotonated using zinc dust and then converted to its N-silylated 
one by treatment with TMS-Cl in presence of zinc dust. After filtering out salts, N-silylated 
amino ester was treated with Fmoc-amino acid chloride to yield peptides in good yields. Neither 
oxazol-5-(4H)-one formation nor the premature deblocking of Fmoc group was observed, as so 
due to the absence of any organic base.226  
 
  Sureshbabu and Gopi applied acid chloride-KOBt protocol for coupling involving 
hindered Fmoc amino acid chlorides.227 Under no base condition, the coupling duration could be 
extended to ensure efficient as well as complete coupling. Significantly, the danger of premature 
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deblocking of Fmoc group does not arise at all. Thus the preparation of α-aminoisobutyric acid 
(Aib) containing fragments of amphipathic peptaibol antibiotics, alamethicin 1-4 fragment Aib-
Pro-Aib-Ala, the emerimicin 2-6 fragment Aib-Aib-Aib-Val-Gly and the Aib tetramer Fmoc-
(Aib)4-OBn were accomplished in good yields and purity.227 Fmoc-amino acid chloride/KOBt 
protocol has also been extended for preparing peptides containing α,α-dialkylamino acids 
including Ac5c, Ac6c, Ac7c, Dbg, and Dpg.76 Also, microwaves assisted zinc dust mediated 
coupling involving highly hindered α,α-dialkylamino acids and cyclic as well as acyclic α,α-
dialkylamino acids has lead to their assembly in good yields of 79-90%.228   
Preparation of hindered peptides possessing up to four successive diphenylglycine or Aib 
residues was accomplished by using azido acid chloride method.133 After coupling the azide 
peptidyl ester was reduced by using dithiothreitol (DTT) and then coupled with another azido 
acid chloride. A sterically demanding peptide H-Thr-Aib-Aib-Aib-Aib-Lys-Ser-Ser-Tyr-Lys-
NH2 was obtained in good yield of about 71%.133 H-Dpg-Dpg-Lys-Ser-Ser-Tyr-Lys-NH2 could 
also be assembled satisfactorily in 60% yield.133                   
5.3. Assembly of peptides containing N-methyl amino acids 
N-Alkylation of peptides results in decreased number of possible hydrogen bonds thereby 
an increased conformational stability. The difficulties encountered during N-alkyl amino acid 
incorporation into peptide sequences were attributed to the severe steric hindrance and cis 
conformation of peptide bond owing to the bulkier N-alkyl group. These features complicate 
peptide synthesis considerably and coupling reactions involving N-methyl amino acids are 
marked by slow coupling, low yields, accompanied by racemization and diketopiperazine 
formation. Also, peptides containing N-alkyl amino acids are acid labile. The reactivity of resin 
bound secondary amines sometimes is even lower compared to reactions in solution and hence 
most of the known coupling protocols are not satisfactory. The target peptides are contaminated 
by truncated sequences due to unattainable acylation and mismatch sequences, thereby making 
the isolation of required peptide cumbersome even by preparative RP-HPLC. On the other hand, 
coupling employing acid chlorides is more than satisfactory. Preformed acid chlorides, with a 
variety of N-protecting groups, have been successfully employed to couple not only amino acid 
chlorides to N-methyl amino acids but also N-methyl amino acid chlorides to N-methyl amino 
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acids. Amino acid chlorides generated in situ have been successfully utilized to assemble even 
four consecutive N-methyl amino acids in solid phase method.  
In a preparation of N-methylated dipeptide methyl esters, Di Gioia et al. employed Fmoc-
amino acid chlorides as coupling reagents with N-methyl amino acid methyl ester under biphasic 
NaHCO3/CH2Cl2 conditions.229 In addition, the N-methyl di as well as tripeptide could be 
coupled with N-Fmoc-amino acid chlorides in standard Fmoc solution phase peptide synthesis to 
obtain corresponding N-Fmoc-tri and tetrapeptides which are N-methylated at the requisite 
amino acid. Methylated as well as sterically demanding Aib containing dipeptides could well be 
made using Bspoc amino acid chlorides,85 Peoc amino acid chlorides192,193and Poc amino acid 
chlorides86 in satisfactory yields in absence of any additive under Schotten-Baumann conditions.  
Also Fmoc-amino acid chloride/KOBt protocol has been utilized for the synthesis of peptides 
containing α,α-dialkyl amino acids as well as N-methyl amino acids (tables 12,13).76 The 
protocol, as indicated by 1H NMR studies, was reported to be free from racemization.  
 
Table 12 Synthesis of sterically hindered peptides  
Entry Peptide Method of coupling Yield 
(%) ref 
Coupling of amino acid chlorides with H-N-Me-amino esters 
1 Fmoc-Val-MePhe-OMe  
aq. NaHCO3/CHCl3, rt 
78 161 
2 Fmoc-Ala-MeVal-OMe 72 161 
3 Fmoc-Ala-MeIle-OMe 98 161 
4 Bts-Leu-MeVal-OtBu Na2CO3/CH2Cl2, rt 95 111 
5 Fmoc-Ala-D-MePhe-Ala-OMe  
 
 
aq. NaHCO3/CHCl3, rt 
92 106 
6 Fmoc-Val-D-MeAla-Val-OMe 94 106 
7 Fmoc-Val-MeLeu-Ala-OMe 93 106 
8 Ns-Val-MePhe-Ala-OMe 86 106 
9 Ns-Val-D-MePhe-Ala-OMe 88 106 
10 Ns-Val-MeIle-Ala-OMe 72 106 
11 Fmoc-Val-MeIle-D-Ala-Val-OMe 83 106 
12 Bts-Leu-MeLeu-MeVal-OtBu Na2CO3/CH2Cl2, rt 98 111 
13 Bts-Ala-MeLeu -MeLeu-MeVal-
OtBu 
99 111 
Coupling of N-Me-amino acid chlorides with H-N-Me-amino esters 
14 Fmoc-MeVal-Sar-OMe TMS-Cl, zinc dust, CHCl3, rt 83 225 
15 Poc-MeAla-MeAla-OMe CHCl3/Na2CO3, -5 to 0 oC 35 86 
16 Bts-MeLeu-MeLeu-MeVal-OtBu CH2Cl2/Na2CO3, rt 99 111 
Coupling of amino acid chlorides with dialkylamino esters 
17 Bts-Phg-Aib-OMe Na2CO3/CH2Cl2, rt 95 110 
18 Ths-Phg-Aib-OMe 64 110 
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Coupling of dialkylamino acid chlorides with amino esters 
19 Fmoc-Dbg-Ala-OMe KOBt, CH2Cl2, rt 85 76 
20 Fmoc-Dbg-Phg-OMe 81 76 
21 Fmoc-Aib-Ala-OBn  
Coupling of dialkylamino acid chlorides with dialkylamino esters 
22 Fmoc-Ac7c-Dbg-OMe KOBt, CH2Cl2, rt 75 76 
23 Fmoc-Ac7c-Ac5c-OMe 70 76 
24 Fmoc-Ac6c-Ac6c-OMe KOBt, CH2Cl2, rt 70 76 
zinc dust, CH2Cl2, MW 89 186 
TMS-Cl, zinc dust, CHCl3, rt 86 225 
25 Fmoc-Deg-Deg-OMe zinc dust, CH2Cl2, MW 81 228 
TMS-Cl, zinc dust, CHCl3, rt 82 225 
26 Fmoc-Ac7c-Ac7c-OMe zinc dust, CH2Cl2, MW 80 228 
27 Fmoc- Ac6c-Ac6c-Ac6c-OMe 79 228 
  
Table 13 Synthesis of sterically hindered Aib peptides  
Entry Peptide Method of coupling Yield (%) 
1      
 
Fmoc-Aib-Aib-OBn zinc dust, CH2Cl2, MW, 90 sec 84 186 
KOBt, CH2Cl2, rt, 20-30 min 83 227 
2        Poc-Aib-Aib-OMe CH2Cl2/Na2CO3, -5 to 0 oC, 15 min 45 86 
3      
 
Fmoc-Aib-Aib-OMe KOBt, CH2Cl2, rt, 20-30 min 85 227 
TMS-Cl, zinc dust, CHCl3, rt, 15-20 min 88 225 
4      Fmoc-Aib-Aib-OEt KOBt, CH2Cl2, rt, 20-30 min 81 227 
5      Fmoc-(Aib)3-OBn KOBt, CH2Cl2, rt -- 227 
6      Fmoc-(Aib)4-OBn 69 227 
7       Poc-(Aib)3-OMe CH2Cl2/Na2CO3, -5 to 0 oC 42 86 
 
5.4. Coupling involving Nα-benzyl/alkyl-Cα,α-dimethylamino acid ethyl esters  
Neither simple amino acids (Ala, Phe) nor Aib were known to couple to H-MeAib. Thus, 
the coupling of Cbz-Aib to H-MeAib-NHMe mediated by bromotri(pyrrolidino)phosphonium 
hexafluorophosphate (PyBroP) in presence of DIEA for two weeks at room temperature gave the 
methyl amide in 3% yield.230 The efficacy of the Tos-Aib-Cl due to greater inductive effect of 
sulfonyl residue was demonstrated by its coupling to obtain Tos-Aib-Aib-OMe in non-aqueous 
conditions to avoid degradation of acid chloride. On a similar strategy Tos-MeAib-Cl 129 
reacted with NMeAib-OMe 130 as well.107 Tos-Aib-Cl and Tos-MeAib-Cl were reported to 
couple with Alloc-MeAib-OMe in 4-8 h under Pd cat./PhSiH3 conditions in 60-65% yield. 
Carpino demonstrated coupling of Pbf-NMeAib-Cl to H-NMeAib-OMe.HCl in toluene in the 
presence of DIEA to afford the extremely hindered dipeptide 131 in 63% yield (Scheme 36).107 
Unlike tosyl group, Pbf group can be deblocked completely using TFA/Me2S, thus opening the 
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avenue for chain extension. However the preparation of Pbf-amino acids is not only multistep 
but also cumbersome.  
O
N Cl
O
S
OO
H2
N OMe
O
DIEA/toluene
O
N
N
O
S
OO
OMe
O
Cl
rt, 2.5 h
yield = 63%
129 131
130
 
Scheme 36. Coupling of Pbf-NMeAib-Cl to H-NMeAib-OMe.HCl in the presence of DIEA. 
Zinc mediated microwave assisted peptide coupling protocol was extended to the 
coupling of N-benzyl-α,α-disubstituted amino acids by Harvey and coworkers.228 The 
BSA/DIEA method resulted in inferior yields for coupling of extremely hindered H-N-Bn-Aib-
OEt to Fmoc-Phe-Cl or Fmoc-Phe-F. Thus Cianci et al. developed an optimized protocol for 
coupling under microwave conditions involving the use of 5 eq of zinc for 2 h at 90 oC in 
CH2Cl2.228 Fmoc-Phe-(N-Bn)-Aib-OEt was obtained by reacting a mixture of H-N-Bn-Aib-
OEt·HCl, Fmoc-Phe-Cl and zinc dust in dry CH2Cl2 at 90 oC for 2 h at 60-70 psi in a CEM 
Discover microwave reactor (Table 14). The peptide was obtained in 61% yield, twice the best 
yield achieved with benchtop conditions (under reflux).  
 
Table 14 Synthesis of sterically hindered N-Me- and N-Bn-Aib peptides228 
 
 
 
 
 
5.5. Cyclosporins and omphalotin A 
Cyclosporins are a family of about 25 peptides and produced by the fungus Beauveria nivea. 
Cyclosporin O and cyclosporine A are sequence-homologous cyclic undecapeptides with seven 
N-methyl amino acid units and known for their antifungal, anti-inflammatory, and 
immunosuppressive activity.231 Omphalotin A, a dodecapeptide containing nine N-methyl amino 
Entry Peptide Method of coupling Yield (%) 
1 Fmoc-Phe-MeAib-OEt zinc, CH2Cl2, 90 oC,    
2 h at 60-70 psi in a 
microwave reactor 
80  
2 Fmoc-Phe-BnAib-OEt 61   
3 Fmoc-Ile-BnAib-OEt 40   
4 Fmoc-Val-BnAib-OEt 54   
5 Fmoc-Pro-BnAib-OEt 46   
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acid residues formed by Basidiomycete Omphalotus olearius, is structurally related to the 
cyclosporins and shows selective activity against phytopathogenic nematodes such as 
meloidogyne incognita and outweighs other known nematicides such as ivermectin in potency 
and selectivity. Several methods including a combination of O-(7-azabenzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HATU) and 1-hydroxy-7-azabenzotriazole 
(HOAt)/N,N'-diisopropylcarbodiimide (DIC), symmetric anhydride coupling using DIC have 
been employed on solid phase with multiple couplings to obtain adequate coupling yields and 
site directed methylation protocol at higher expenses of reagents. 
Rich group reported the synthesis of D-lysine8-cyclosporine A wherein the Fmoc–
protected tetrapeptide FmocMeLeu-Val-MeLeu-Ala-OBn was prepared using Fmoc-MeLeu-Cl 
as acylating reagent in 86% yield (AgCN, CH2Cl2, room temperature).232 Also Fmoc-Val-Cl was 
employed to obtain the tripeptide Fmoc-Val-MeLeu-Ala-OBn in 61% yield comparable to that 
obtained with N,N'-bis(2-oxo-3-oxazolidinyl)-phosphinicchloride (BOP-Cl) mediated 
coupling.233 
  Vedejs and Kongkittingam reported the synthesis of cyclosporine 8-11 tetrapeptide 
subunit (D-Ala-MeLeu-MeLeu-MeVal-OtBu) using Bts-protected amino acid chlorides (Scheme 
37).111 N-Methylamino ester could be efficiently coupled to Bts-N-methyl amino acid chloride 
under Schotten-Bauman conditions in excellent yield. However for reasons of step economy, 
subsequently N-methyl amino esters were coupled to Bts-protected amino acid chlorides 134 and 
the Bts-dipeptide 135 was then N-methylated and finally deprotected using PhSH/K2CO3. Both 
RP-HPLC and NMR studies showed no incomplete coupling or incomplete N-methylation and 
that coupling, N-methylation and deprotection survived epimerization and > 99.5% ee and ds 
could be obtained. Thus the tetrapeptide subunit has been assembled in 74-80% overall yield in 
solution including three repeated cycles of N-methylation, deprotection, and peptide coupling. 
The final product was obtained in high purity without chromatographic purification or 
crystallization by simple acid/base extraction itself.  
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Scheme 37. Synthesis of cyclosporine 8-11 tetrapeptide subunit (D-Ala-MeLeu-MeLeu-MeVal-
OtBu) using Bts-amino acid chlorides. 
Jung et al. reported solid phase synthesis of cyclosporine O employing BTC and a 
combination of collidine (for preactivation of carboxy component) and DIEA (for pretreatment 
of the resin) at room temperature (Scheme 38).234 The highly acid labile trityl chloride 
polystyrene resin was chosen due to the acid lability of N-methylated peptides. A comparative 
study involving coupling of amino acids Fmoc-Trp(Boc)-OH, Fmoc-Val-OH, Fmoc-Sar-OH and 
Fmoc-MeVal-OH onto resin bound MeVal-Phe showed superiority of the BTC method over that 
of HOAt/DIC, symmetrical anhydride coupling using dicylcohexylcarbodiimide (DCC), acid 
fluoride activation by tetramethylfluoroformamidinium hexafluorophosphate (TFFH). However 
original BTC method which involves heating at 50 oC, was unsuccessfull at the stage of 
pentapetide, without any cleavage product (Fig. 6). Thus coupling condition was modified using 
a combination of bases for the preactivation and the coupling of amino acids, collidine and DIEA 
respectively and the coupling was carried out at room temperature in THF. The permethylated 
tetrapeptide H-MeLeu-MeLeu-MeVal-MeLeu-OH was obtained in over 99% yield, with 
coupling for 3 h or less at room temperature. Finally, the deprotected linear undecapeptide of 
cyclosporin O was obtained in a purity of 90%. However coupling of unmethylated amino acids 
proved problematic which was overcome by additional coupling cycle using HOAt/DIC for 16 h, 
except for BTC mediated coupling of norvaline (Nva). 
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Quantitative comparison of the methods for the coupling of different amino acids onto MeVal-
Phe-TCP-resin is as follows, 
Coupling method Fmoc-Ile-OH Fmoc-Sar-OH Fmoc-MeVal-OH Fmoc-Trp(Boc)-OH 
BTC + + + + 
HOAt XX + XX X 
TFFH XX X X XX 
DCC XX + XX XX 
+: chloranil test is negative, indicating complete reaction. 
X: chloranil test slightly positive 
XX: chloranil test positive 
(Sar = sarcosine) 
Figure 6. Comparison of the methods for the coupling of different amino acids onto MeVal-Phe-
TCP-resin. 
 
The modified BTC coupling was also utilized in the total synthesis of omphalotin A using 
TCP resin preloaded with sarcosine, a combination of BTC protocol and DIC/HOAt, HATU (for 
insertion of unmethylated amino acids) couplings. The linear dodecapeptide with C-terminal Sar6 
was obtained in 84% yield and 90% purity. Diastereomerically pure omphalotin A (145) was 
obtained in 37% yield after cyclization and an overall yield of 31% with respect to the first 
loading of the resin with Fmoc-sarcosine (Scheme 39).235  
Sewald has highlighted the efficient solid phase assembly of cyclosporin O and 
omphalotin A via BTC activation.236 Peptide macrocyclization by activation of C-terminal resin 
bound sarcosine residue was found superior than from resin bound MeIle due to considerable 
racemization in the latter case. 
An elegant synthesis of cyclosporin O (140) was carried out by step-by-step linear 
condensation approach by employing Fmoc-amino acid chlorides under neutral conditions in the 
presence of zinc in solution (Scheme 38).237 The amino free peptide benzyl esters were coupled 
directly to the next amino acid without isolation. All the ten intermediate Fmoc-protected peptide 
fragments were isolated in good yields (above 90%). Coupling of consecutive N-methyl amino 
acids could result in upto 73-79% yield. The cyclization of free undecapeptide was achieved in 
85% yield with HATU in CH2Cl2. Starting from dipeptide, cyclosporine O (140) was obtained in 
an overall yield of 15-18%. 
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Scheme 38.  Synthesis of cyclosporine O using BTC and zinc dust methods. 
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Scheme 39. Synthesis of omphalotin A using BTC method. 
5.6. Petriellin A 
Hughes and coworkers reported solid phase synthesis of the antifungal highly modified cyclic 
depsipeptide petriellin A (147) in an overall 5% yield using 2-chlorotritylchloride (ClTrt) resin 
and Fmoc amino acid derivatives (Scheme 40).238 Solution phase synthesis was employed for the 
preparation of depsipeptide fragment by Mitsunobu esterification between Fmoc-L-pipecolic acid 
and the L-phenyllactate derivative. The depsipeptide fragment and other N-alkyl amino acid 
residues were coupled to growing resin bound peptide by modified BTC method developed by 
Jung et al. whereas coupling involving unalkylated residues were brought about by O-
(benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate/1-hydroxybenzotriazole 
(HBTU/HOBt). After resin cleavage, the crude linear precursor was isolated in 58% yield, as 
calculated from the loading of the first residue. The cyclization at the Ala-Pro junction was 
conducted in high dilution to obtain the cyclized target molecule. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
57 
 
 
Scheme 40. Synthesis of petriellin A using BTC method. 
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6. Applications  
6.1. Amino acid derivatives  
A large number of amino acid derivatives have been prepared by acylation of nitrogen 
and oxygen nucleophiles with protected amino acid chlorides. These include, Fmoc-protected 
amino/peptidyl Weinreb amides 148, hydroxamic acids 149, pseudoproline analogs 153, Pfp and 
3,4-dihydro-4-oxo-1,2,3-benzotriazine-3-yl (Dhbt) esters 155 of Fmoc amino acids and α-amino-
α'-ketols 151 (Scheme 41). 
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Scheme 41. Synthesis of various amino acid derivatives using protected amino acid chlorides. 
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6.1.1. Weinreb amides  
Fmoc-protected amino/peptide acid chlorides generated using SOCl2 under 
ultrasonication were treated with N,O-dimethylhydroxylamine hydrochloride in the presence of 
NMM to obtain corresponding Weinreb amides 148 in two steps in good yields and purity 
(Scheme 41).239  
6.1.2. Hydroxamic acids 
Two derivatives of hydroxyl amine, N-Boc-O-(THP) (THP = tetrahydropyran) and N-
Boc-O-TBDMS were employed for the synthesis of N,O-bisprotected hydroxamic acids by 
reaction with various carboxylic acid chlorides.240 A deprotection step is necessary after the 
acylation of hydroxyl amine derivative. Sureshbabu and Hemantha reported a simplified 
synthesis of Fmoc-amino acid hydroxamates by direct acylation of hydroxylamine using Fmoc-
amino acid chlorides in presence of excess of MgO in one step.241 Hydroxyl amine hydrochloride 
was deprotonated using an equivalent of MgO in methanol/water, and treated with Fmoc-amino 
acid chloride using 2 eq of MgO.  
Malkov and coworkers242 employed amino acid-derived hydroxamic acids 149 as chiral 
ligands in the vanadium catalysed epoxidation of various allylic alcohols (Scheme 41). The N-
benzenesulfonyl or mesyl protected amino acid chlorides were reacted with benzhydryl 
hydroxylamine at low temperature to obtain required hydroxamic acids. Under these conditions, 
the competing O-acylation of the hydroxylamine was reduced to less than 5% and chiral HPLC 
analysis showed that reaction proceeded with > 99% ee.    
6.1.3. 2-CF3-1,3-Oxazolidine (Tfm-pseudoproline) containing dipeptides 
Chaume et al.243 employed acid chloride strategy to overcome low nucleophilicity of 
amino group of CF3-oxazolidine pseudoproline 152 in synthesis of dipeptides 153 incorporating 
one CF3-ψPro and studied their conformational features. Methyl-(2R,4S)-CF3-pseudoprolinate 
was coupled with o-Nbs-Ala-Cl (generated in situ using 1-chloro-N,N-2-trimethyl-1-
propenylamine) and Fmoc-Ala-Cl to obtain diastereomeric peptides (Scheme 41) in good yields 
(> 70%), which were then purified by flash chromatography. 
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6.1.4. 3,4-Dihydro-4-oxo-1,2,3-benzotriazine-3-yl (Dhbt) and pentafluorophenyl (Pfp) esters 
A one pot preparation of 3,4-dihydro-4-oxo-1,2,3-benzotriazine-3-yl (Dhbt) 155 and two 
step preparation of Pfp esters 157 involving Fmoc amino acid chlorides as intermediates were 
reported by Jacobsen et al.244,245 The method avoids the side reaction of formation of azido 
benzoyl derivative that prevail when conventional DCC method was employed (Scheme 41).   
6.1.5. Hydroxyurea and hydantoin derivatives 
Several L- and D-amino acid derivatives of hydroxyurea 160 were prepared by aminolysis 
of N-(1-benzotriazolecarbonyl)amino acid amides 159 with hydroxylamine.122 These amides 
were obtained from corresponding Btc-amino acid chlorides 158. Similarly, hydantoin 
derivatives 161 are accessed by base catalyzed cyclization of these intermediate amides 159 
(Scheme 42).   
 
Scheme 42. Synthesis of hydroxyurea and hydantoin derivatives. 
6.1.6. Aryl amides 
The very first application of Fmoc-amino acid chlorides involved coupling of in situ 
generated Fmoc-amino acid chlorides with 5-bromo-7-nitroindoline for the preparation of 
corresponding 5-bromo-7-nitroindolinyl derivatives.75b The reaction was carried out by heating a 
mixture of  Fmoc-protected amino acid, SOCl2 and 5-bromo-7-nitroindoline in toluene, at 40-70 
oC for several hours to yield the desired amides in high optical purity (99.5 ± 0.5% ee). 5-Bromo-
7-nitroindolinyl derivatives were then employed in photochemical coupling of peptide segments.  
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Spivey et al.246 reported solid phase synthesis of cyclic diphenylacetylene (tolan) amino 
acid constrained peptidomimetic containing the 21-residue epitope present in the A-B loop of the 
Cε3 domain of the human immunoglobulin E (hIgE). The serine amide building block 164 was 
synthesized by coupling Fmoc–Ser(tBu)-Cl 162 with 2,2,2-tribromoethyl-4-amino-3-
iodobenzoate 163 in presence of AgCN in 93% yield (Scheme 43). Initial attempts to form amide 
bond by employing standard coupling agents and additives failed to afford the desired product. 
The synthesis of linear peptide having the IgE Cε3 sequence 358-340 fragment was then carried 
out using Rink amide functionalized polystyrene resin. Finally the peptide macrocyclization was 
effected by Sonogashira cross coupling of 2-ethynylbenzoic acid and 4-amino-3-iodobenzamide 
on solid phase in presence of Pd(PPh3)2Cl2, CuI, and TEA. The resulting cyclized product 165 
was purified by RP-HPLC (~15% yield).  
Scheme 43. Synthesis of cyclic diphenylacetylene (tolan) amino acid constrained peptidomimetic. 
N-[Chloro(dimethylamino)methylene]-N-methylmethanaminium chloride (TMUCl Cl) 11 
has been employed for the solid-phase organic synthesis of anilides from supported carboxylic 
acids through corresponding acid chloride activation.23 The method was found efficient when 
compared to the N,N'-carbonyldiimidazole (CDI) activation. Thus three different aromatic 
amines (benzidine, 4,4'-tiodianiline and 4-nitroaniline) were incorporated to side chain 
carboxylic acid of Glu anchored onto Rink-PS-resin in high yields (Scheme 44). Also the study 
involved condensation of [±]-2-[N-phenylethyl-N-propyl]amino-5-hydroxytetralin {[±]-PPHT}, 
a selective and potent agonist of D2 dopamine receptor with Glu residue supported onto 
polystyrene (PS) resin 166. In a comparative study, TMUCl Cl was found to yield highest 
conversion of 62% when compared to CDI and 2,4,6-trichloro[1,3,5]-triazine (TCT) (46% and 
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40% respectively). The HPLC analysis of diastereomers indicated 15% racemization for this 
demanding condensation. 
H
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Scheme 44. Solid-phase synthesis of anilide using TMUCl Cl. 
Xanthone amine derivatives 170 were reacted with excess amino acid chlorides 169 in 
dry THF at room temperature for 10 min to obtain various artificial xanthone based nucleophiles 
with oxyanion hole structure combined with amino groups (Scheme 45).247 Excess acid chloride 
was hydrolyzed by heating with water at 50 oC. The aqueous work up followed by 
recrystallization of crude material from methanol/water lead to the isolation of nucleophiles in 
good yields. Catalytic activity of xanthone based nucleophiles for enantioselective Michael type 
addition of ethanethiol to the 5,6-dihydro-2-(H)-pyridinone was studied. Relative position of the 
basic catalytic group in the nucleophile was varied by using various amino acid derivatives with 
different side chains. The proline derived nucleophile showed good catalytic activity as well as 
high asymmetric induction.    
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Scheme 45. Coupling of amino acid chlorides with xanthone amine derivatives. 
6.1.7. Diazoketones and homologation to β-amino acids  
              Nα-Protected aminodiazoketones 177 are useful intermediates for synthesis of β-amino 
acids and their derivatives.248 Ye and Mckervy 249 treated EtOCO-α-amino acid chlorides with 
ethereal solution of CH2N2 and the resulting α-diazo ketones were lithiated and then condensed 
with aldehydes or ketones (Scheme 46). Thus obtained α-diazoketols were rearranged to 
homochiral α-amino-β-diketones on treatment with rhodium(II) acetate. In another report, N-Cbz 
protected amino acid chlorides were converted to corresponding diazoketones (only three 
examples illustrated) which were used as one of the components in synthesis of di(N-protected-
α-amino)diazo-β-diketones 176.250  
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Scheme 46. Synthesis of Nα-protected aminodiazoketones and di(N-protected-α-amino)diazo-β-
diketones. 
Liguori et al. reported the stereospecific homologation of the Fmoc-α-amino acids to their 
β-homologues via acid chlorides.251 N-Fmoc-amino acid chlorides were treated with 0.66 M 
solution of CH2N2 in CH2Cl2, to obtain α-aminoacyldiazomethanes in 92-97% yield, without any 
detectable racemization as confirmed by 1H NMR study of (2S,3S)-isoleucine as a test case. 
Similarly N-nosyl-α-aminoacyl chlorides were also converted to corresponding N-methyl-N-
nosyl-α-aminoacyldiazomethanes and then subjected to Wolff rearrangement in presence of 
silver benzoate to obtain N-methyl-Nosyl-β3-amino acids.107 
Pettit et al. converted γ-carboxyl group of L-glutamic acid derivatives by using oxalyl 
chloride in THF and catalytic DMF followed by treatment with diazomethane at -23 oC.252,253 
6.1.8. Friedel-Crafts reaction: Chiral aryl-α-amino ketones  
The utilization of N-protected amino acid chlorides in Friedel-Crafts reaction to obtain 
dissymmetric aromatic amino ketones 183 has been explored since long time. Chiral aryl-α-
amino ketones have been used as drugs in the treatment of nicotine dependence, as late life 
antidepressants. Though phthaloyl, tosyl, acetyl, benzoyl, methyloxy, ethyloxy, TFA protecting 
groups were compatible with the Friedel-Crafts acylation conditions, difficulties during the 
deprotection step and partial racemization hampered their general utility.  
The use of N-methoxycarbonyl-Phe-Cl/Ala-Cl in Friedel-Crafts acylation affords about 
60% yield with chiral purity of 96-98% as determined by chiral shift 1H NMR analysis.95 N-Cbz-
Phe-Cl found to yield only intractable tars when reacted with AlCl3. However the  
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corresponding methoxycarbonyl derivative underwent Friedel-Crafts cyclization in 55-75% yield 
with chiral purity of > 98%. N-Methoxycarbonyl alanyl chloride provided acyclic N-protected α-
amino ketone in 50-60% yield but found to contain 3-4% of epimer (Scheme 47).  
 
Scheme 47. Use of N-protected amino acid chlorides in Friedel-Crafts reaction.  
Buckley and Rapoport91 employed similar chemistry using Etoc-alanyl chlorides as a 
chiral educt for the synthesis of α-aminoalkyl aryl ketone. Xu et al. utilized ethoxycarbonyl-Phe-
Cl in Freidel-Crafts cyclization and the resulting product was employed to prepare optically 
active trans-(1S,2S)-1-substitued-2-(N,N-dialkylamino)-1-indanol derivatives.94 Nordlander et 
al.115,254,255 demonstrated similar chemistry using TFA-α-amino acid chlorides as chiral reagents 
for Friedel-Crafts reactions. Herein benzene, anisole, and veratrole underwent reaction in 
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presence of anhydrous AlCl3 or SnCl4 with > 99% preservation of chiral integrity. The ketones 
were reduced under neutral conditions using Et3SiH or H2/Pd-C to the corresponding TFA-β-
hydroxy-β-arylalkylamines or TFA-β-arylalkylamines without loss of enantiomeric purity. The 
latter were then employed to obtain 3-substituted 1,2,3,4-tetrahydroisoquinolines. 
 
Di Gioia et al.256a developed an elegant one pot process for Friedel-Crafts type 
reaction/deblocking of Fmoc-amino acid chlorides with toluene in presence of AlCl3 controlling 
both stoichiometry and reaction duration. Herein a solution of Fmoc-amino acid chloride in 
toluene was treated with three fold excess of AlCl3, at room temperature for 2 h. The desired free 
base aryl-α-amino ketone was separated by simple hydrolytic work up under basic conditions, 
followed by solvent extraction (Scheme 48). The treatment of organic layer with acetic 
anhydride afforded the N-acetylated ketone in 89% yield. The protocol could be extended for the 
preparation of modified dipeptides and a tripeptide as well. The peptide analogs could be 
obtained in high yields and without the need for any chromatographic purification. The 1H NMR 
analysis of reaction crudes of diaseteromeric modified dipeptides obtained by coupling of Fmoc-
L-valine chloride with epimers of 2-amino-1-p-methylphenyl-propanone confirmed total 
retention of chiral integrity of either precursor or product. The GC-MS and 1H NMR analysis of 
N-acetylated derivatives also confirmed presence of single diasteriomer. The free base chiral 
aryl-α-amino ketones 187 underwent coupling with Fmoc-amino acid chloride to obtain 
dipeptidyl ketones 190 as well. Aryl peptidyl ketones could be reduced in presence of titanium 
tetrachloride as the chelating agent to the corresponding amino alcohols 191.256b 
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Scheme 48. Synthesis of chiral aryl-α-amino ketones and dipeptidyl ketones. 
6.1.9. Reaction with Grignard reagent and other organometallic reagents 
Schrey et al.257 reported synthesis of enantiopure cis- and trans-2,5-disubstituted 
tetrahydrofuran amino acids starting from tosyl-amino acid chlorides. Reaction of 
butenylmagnesium chloride 193 with N-tosyl alanyl chloride 192 resulted in 64% yield of the 
ketone 194 (Scheme 49). The yield was improved to 94% by conversion of Grignard reagent to 
organocopper species prior to reaction with the acid chloride. The ketone was subjected to L-
selectride reduction and subsequently transformed into enantimerically pure trans- and cis-
tetrahydrofuran (THF) amino alcohols 195a and 195b, which were eventually converted to the 
corresponding Boc and Fmoc protected THF amino acids. The acid chloride was found to be a 
superior starting material than the lithium N-tosylalaninate, which affords the corresponding 
ketone in 40% yield only. 
N
H O
ClTos
MgBr
Et2O, -78 oC - rt
12 h
N
H O
Tos
yield = 64%
ONH OHTos H H
+ ONH OHTos H H
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Scheme 49. Synthesis of cis- and trans-2,5-disubstituted tetrahydrofuran amino acids by reaction 
of Tos-amino acid chloride with Grignard reagent. 
In a synthesis of 6,7-dihydroeponemycin (200a), a peptide epoxide with potent cytotoxic 
and antiangeogenesis activity, Bennacer et al.258 employed Pd(0) catalysed Stille couping of 
Fmoc-Ile-Cl 196 with tributylvinyltin 197 in 4-(hydroxylmethyl)phenoxyacetic acid (HMPA) at 
20 oC in 60-80% yield with 98% ee (Scheme 50). The Stille product was then subjected to 
conjugate addition with PhSAlMe2, S-oxidation, and heat induced syn elimination to obtain an 
enone intermediate, which was converted to 1 : 1 diastereomeric mixture of epoxides, which 
could be separated through silica gel chromatography. Finally individual diastereomers are 
converted into dihydroeponemycin (200a) and (2S)-epi-dihydroeponemycin (200b) in a four step 
one pot protocol. 
 
Scheme 50. Pd(0) catalysed Stille couping of Fmoc-Ile-Cl with tributylvinyltin and synthesis of 
dihydroeponemycin (200a) and (2S)-epi-dihydroeponemycin (200b). 
Etoc-amino acid chlorides 202 were used for the synthesis of α-amino acid isoxazolidides 
204 derived from Ala, Phe, and Met and subsequently employed for the preparation of optically 
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pure α'-amino-α,β-ynones 206 by reaction with lithium acetylides 205 (Scheme 51). However 
direct reaction of acid chloride with lithium acetylide lead to < 5% yield of respective ynone 208, 
producing largely the corresponding tertiary alcohol 209.93,249,259  
 
Scheme 51. Synthesis of α-amino acid isoxazolidides and α'-amino-α,β-ynones. 
 
6.1.10. Kinetic resolution of heterocyclic amines  
Levit’s group studied kinetic resolution of heterocyclic amines using phthaloyl protected 
amino acid chlorides 210 as enantiopure acylating agents.126,260 Acylation of racemic 
heterocyclic amines, 2-methyl-1,2,3,4-tetrahydroquinoline, 2,3-dihydro-3-methyl-4H-1,4-
benzoxazine and 2-methyl indoline with N-phthaloyl-(S)-alanyl chloride under kinetic resolution 
conditions lead to diastereomeric amides 212 enriched with (S,S) amides with de 40%, 53% and 
19% respectively. Recrystallization of the (S,S) amides from hexane-EtOAc resulted in high 
diastereomeric excess (de > 99.5%) of individual diastereomer. However amide from 2-
methylindoline could only be obtained as 1 : 1 ratio of (S,S)- and (R,S)-amide (Scheme 52). 
(S,S)-Amides are then hydrolyzed in a mixture of conc. HCl and glacial CH3CO2H at reflux, to 
obtain individual (S)-isomers of amines 214 in 95% yield.  
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Scheme 52. Kinetic resolution of heterocyclic amines using phthaloyl protected amino acid 
chlorides. 
Resolution of racemic 2-methyl-1,2,3,4-tetrahydroquinoline and 2,3-dihydro-3-methyl-4H-1,4-
benzoxazine, which are biologically important structural fragments, was studied using N-
phthaloyl-(S)-alanyl chloride, N-phthaloyl-(S)-phenylalanyl chloride as well as N-phthaloyl-(S)-
phenylglycyl chloride. Kinetic resolution of racemic amines with acyl chlorides followed by 
recrystallization lead to isolation of major (S,S)-diastereomeric amides in enantiomerically pure 
form (de > 97%).261 Solvents CH2Cl2, CH3CN and low temperature has been found to improve 
the selectivity of acylation of amines. The acyl chlorides with aromatic substituents close to the 
stereogenic centre proved to be more stereoselective and N-phthaloyl-(S)-phenylalanyl chloride 
has been found appropriate chiral acylating agent.  
Electronic effects of para substituents (NO2, H, OCH3) of phenyl ring of N-phthaloyl-(S)-
phenylalanyl chloride was also studied.262 An increase in the electron donating property of the 
phenyl fragment in acyl chloride lead to an increased effectiveness of acylative kinetic resolution 
of 2-methyl-1,2,3,4-tetrahydroquinoline and 2,3-dihydro-3-methyl-4H-1,4-benzoxazine. 
6.2. Heterocycles 
6.2.1. N-Carboxyanhydrides (NCA) and urethane protected N-carboxyanhydrides 
(UNCAs) 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
71 
 
α-Amino acid N-carboxyanhydrides were discovered by Leuchs64-66 from N-ethoxycarbonyl or 
N-methoxycarbonyl amino acid chlorides. Also, Cbz-amino acid chlorides undergo spontaneous 
decomposition to NCA’s at high temperatures. 
In practice, N-bis-Boc-amino acid and N-Boc,Cbz-amino acid chlorides 215 can be used 
to obtain  Nα-Boc-NCAs and Nα-Cbz-NCAs 216 respectively by SOCl2 method.263 Synthesis of 
Boc- and Cbz- amino acid N-carboxyanhydrides was demonstrated by the action of Vilsmeir 
reagent SOCl2/DMF on the pyridinium salts of bic(Boc)amino acids.264,265 Thus, when at least 
one of the alkoxy groups is Boc, the cyclization involving the participation of tert-butyl 
carbamate occurred under mild conditions (0 oC) with high yields of UNCA (Scheme 53). This 
method avoids the use of phosgene and other unstable reagents such as tert-butyl chloroformate 
and NCAs. It is obvious that the method cannot be extended to Fmoc-NCAs.  
 
Scheme 53. Synthesis of Nα-Boc-NCAs and Nα-Cbz-NCAs from N-bis-Boc-amino acid and N-
Boc,Cbz-amino acid chlorides. 
Smeets et al. reported leucine-NCA synthesis using corresponding acid chloride 
hydrochloride salt which has been successfully scaled up, maintaining high product purity on a 
1.0 dm3 scale.266 
6.2.2. Fused 1,2,5-triazepine-1,5-diones  
In a synthesis of fused 1,2,5-triazepine-1,5-diones 219 which mimic cis-peptidyl 
prolinamides, Lenman et al.267 employed acid chloride activation using SOCl2 in pyridine for the 
difficult coupling reaction between N-chloroacetyl-(2S)-proline (217) with the sterically hindered 
secondary amino group of the hydrazide (Scheme 54). Due to the steric bulkiness on the 
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coupling nitrogen of the hydrazide, activation of the carboxylic acid by reagents including 
isobutyl chloroformate, 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride 
(EDCI), TBTU, benzotriazol-1-yloxytri(pyrrolidino)-phosphonium hexafluorophosphate 
(PyBOP) and diphenylphosphoryl azide (DPPA) failed to deliver the desired compound. 
However, activation by preformed acyl pyridinium salt could yield the required peptidic ester in 
53% yield.  
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Scheme 54. Synthesis of fused 1,2,5-triazepine-1,5-diones. 
 
6.2.3. Asparagine derived tetrahydropyrimidinones  
Konopelski et al. developed dipeptide surrogates 224 containing asparagine derived 
tetrahydropyrimidinones by treating the imine 221 derived from 4-chloro-3-nitrobenzaldehyde 
and tert-butyl-L-asparaginate with Fmoc-amino acid chloride in anhydrous benzene in the 
presence of pyridine (Scheme 55).268,269 The acid chloride reacted efficiently with weak 
nucleophile such as an imine. However other coupling methods including active ester, anhydride, 
acyl fluoride and acyl imidazole gave inferior results. The yields varied from 58-66% for a range 
of amino acid side chains including Pro. These tetrahydropyrimidines have known absolute 
configuration and conformation, thus their incorporation into oligopeptides by SPPS could result 
in stereochemically defined peptidomimetics. As a demonstration, the tetrapeptide as the Fmoc-
protected primary amide was synthesized by SPPS in good yield.  
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Scheme 55. Synthesis of asparagine derived tetrahydropyrimidinones. 
6.2.4. α-Methyltryptophan analogs 
A highly stereocontrolled synthesis of (R)-α-methyltryptophan 230 and its orthogonally 
protected analogs 231, 232 and 233 has been carried out by Goodmann in a four step conversion 
from Ala (Scheme 56).270 The method involved the stereoselective alkylation of salicylaldehyde 
derived oxazolidinone by N-protected 3-bromomethyl indole, a strategy initially developed by 
Zydowsky and coworkers.271 The Schiff base intermediate 227 was treated with BTC to generate 
the required oxazolidinone 228 at moderate yields of 45-57%. The method is particularly 
attractive for amino acids with acid labile side chains, as the alkylated intermediates could be 
removed under basic conditions. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
74 
 
OH
O
NH2
OH
N O
OH
O
O
H
O
O
H
OH
CHO
NaOH, MeOH
 4 Ao MS, rt
BTC, K2CO3
N
H
O
OH
CH3
NH2
CH2Cl2
yield = 45-57%
226
227 228
231
N
Boc
Br
LiHMDS/DMPU
         THF
O
O
O
O
H
N
Boc
N
Boc
O
OH
CH3
NHFmoc
N
Boc
CH3
OO OMe
F3C
230
233 232
229
225
 
Scheme 56. Synthesis of (R)-α-methyltryptophan 230 and its orthogonally protected analogs. 
6.2.5. Demethoxyfumitremorgin C analogs 
Demethoxyfumitremorgin C, most active fungal natural product that causes eukaryotic 
cell cycle arrest at the G2/M transition possesses tetrahydro-β-carboline and diketopiperazine 
rings. Demethoxyfumitremorgin C and its analogs were synthesized using solid phase N-
acyliminium Pictet-Spengler condensation followed by cyclative cleavage forming the 
piperazine ring.272 Thus Fmoc-L-tryptophan immobilized on the polystyrene-Wang resin 234 was 
deprotected and reacted with senecialdehyde (Scheme 57). The key step involved the reaction of 
imine with N-Fmoc-proline chloride inducing N-acyliminium Pictet-Spengler condensation. The 
Fmoc deprotection lead to cyclative resin cleavage by piperazine ring closure giving 
demethoxyfumitremorgin C 235 and its trans epimer. Various analogs 236 were also synthesized 
by varying the aldehyde and amino acid chloride components to obtain target compounds in 
good yields. 
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Scheme 57. Synthesis of demethoxyfumitremorgin C and its analogs using solid phase N-
acyliminium Pictet-Spengler condensation. 
6.2.6. Fumiquinazoline alkaloids 
Biomimetic total syntheses of fumiquinazoline alkaloids 239 namely glyantrypine, 
fumiquinazoline F, fumiquinazoline G, and fiscalin B were achieved in four steps starting from 
methyl tryptophanate.273 Condensation of the dipeptide ester (obtained from coupling of 
anthranilic acid with methyl-D-tryptoyphanate) with Fmoc amino acid using PyBroP led to lower 
yields (35%) of the product (Scheme 58). On the other hand, corresponding acid chloride 
employed under Schotten-Baumann conditions resulted in linear tripeptides 238 in high yields of 
97-98% in 2 h. The resulting products were then dehydrated to benzoxazines and then 
subsequently rearranged to natural products. 
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Scheme 58. Syntheses of fumiquinazoline alkaloids. 
6.2.7. Pictet-Spengler reaction: β-Carbolines  
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Phthaloyl amino acid chlorides were employed as removable chiral auxiliaries in the 
asymmetric Pictet-Spengler reaction for synthesis of β-carbolines 242 with very high levels of 
stereoselectivity (> 99 : 1; Scheme 59).129,274,275 The Schiff bases derived from tryptamine were 
treated with 2 eq of acid halide in presence of 2 eq of titanium alkoxide in CH2Cl2 at room 
temperature within 5 min to 1 h. In case of aromatic Schiff bases, longer reaction periods 
(several days) are required and the diastereomeric ratio found to increase with increasing steric 
demand of amino acid side chain. The proposed pathway of reaction involved attack of acid 
chloride on nitrogen of imine resulting in N-acyl iminium intermediate 241, which undergoes 
Pictet-Spengler cyclization by the attack of electron rich nucleophilic indole C-2 carbon on the 
iminium ion. The stereoselectivity observed found to depend on amino acid side chains, nature of 
imine substituent, and the alcohol incorporated in the titanium lewis acid. Other protecting 
groups namely Fmoc and Cbz, lead to lower stereoselectivity. The use of phthaloyl group lead 
not only to high diastereoselectvity but also highly crystalline compounds could be obtained.  
Cl
O
R1
N
O
O
+ CH2Cl2, rt
N
H
N
R
30 min - 8 days NH
N
R
O
N=Pht
R1
Cl N
H
N
R
O
N=Pht
R1
N
H
N
R
O
N=Pht
R1
+
242a
242b
yield = 30-99%
240
241
Ti(OiPr)4
210
 
Scheme 59. Phthaloyl amino acid chlorides as chiral auxiliaries in the asymmetric Pictet-
Spengler synthesis of β-carbolines. 
6.2.8. Benzofused bicyclic azepinones 
Robl et al. reported synthesis of benzofused bicyclic azepinones 246, 7,5- and 7,6-fused 
compounds, wherein N-phthalimido-γ-benzyl-L-aspartic acid was coupled to methyl (S)-1,2,3,4-
tetrahydroquinoline-2-carboxylate through acid chloride activation (Scheme 60).276 The coupling 
of acid chloride with the desired amine under Schotten-Baumann type conditions at room 
temperature for 18 h lead to the product in 86% yield with high diastereomeric purity (de 99.4% 
by HPLC). However the acylation using acid fluoride was unsuccessful.  
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Pht=N
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O H2N
N
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yield = 86%
HN
COOMe
TsOH.
aq. NaHCO3
toluene, rt COOMe
18 h
244
245 246243
 
Scheme 60. Synthesis of benzofused bicyclic azepinones. 
6.2.9. Substituted hydroxyproline based 2,5-diketopiperazines  
Bianco et al. reported solid phase synthesis of highly substituted hydroxyproline-based 
2,5-diketopiperazines containing the trans-L-Pro residue (Hpp) (Scheme 61).277 The key step 
involved the difficult acylation of pyrrolidine nitrogen which was carried out using two 
approaches. In the first, Fmoc-amino acid fluoride was coupled to hindered amino function of 
pyrrolidine by silylation using BSA. Coupling was repeated two to three times and the formation 
of 2,5-diketopiperazine initiated immediately during the cleavage of Fmoc-group. In a second 
approach, azido acid chloride was employed to acylate the nitrogen of hydroxyproline, which 
required shorter reaction time and without multiple coupling. The azide moiety was reduced 
using suspension of SnCl2, TEA, thiophenol in THF. The resin was then heated in DMF in the 
presence of KCN as catalyst to complete cyclization to 2,5-diketopiperazine 250. 
O
N
R1
COOMe
Teoc
(a) tetrabutylammonium
 fluoride (TBAF), THF
(b)
N3
R
COCl
DIEA/CH2Cl2   
     rt, 2 h
O
N
R1
COOMe N
O
OHO R1
R2
RO
R
N3
247 248
249
250
Teoc = trimethylsilyl ethoxycabonyl group
15 compounds
 
Scheme 61. Solid phase synthesis of highly substituted hydroxyproline-based 2,5-
diketopiperazines. 
6.2.10. Azetidine-2-ones 
N,N-Dibenzyloxycarbonylglycyl chloride 25 has been employed as ketene equivalent in 
the synthesis of N,N-dibenzyloxycarbonylaminoazetidin-2-ones 252 as well as C-4 substituted 
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azetidinones 254 (Scheme 62). Reaction of N-allyl, N-benzyl, and N-p-
methoxyphenylhexahydrotriazines with N,N-bis-Cbz-glycyl chloride in presence of TEA at -40 
oC afforded corresponding lactams in 57-80% yield. Also N,N-bis-Cbz-glycyl chloride can be 
reacted with imines under similar conditions, to obtain C-4 substituted azetidinones with cis 
isomer as major product 256.70 
 
Scheme 62. Synthesis of azetidin-2-ones using N,N-dibenzyloxycarbonylglycyl chloride as a 
ketene equivalent.  
 
6.3. Peptidomimetics 
6.3.1. Hydrazino-tethered dipeptides, N-hydroxy tethered tripeptidomimetics 
Killian et al.278 studied the ribosome mediated incorporation of the (S)-α-
hydrazinophenylalanine into modified peptide and protein analogs using (S)-α-
hydrazinophenylalanyl-tRNA as the A-site tRNA (Scheme 63). Thus synthesized dipeptide 
product mixtures were analyzed by HPLC in comparison with peptides prepared through 
chemical means using acid chloride strategy. Herein N-Fmoc-(S)-Phe-Cl was coupled with 
methyl-N-Boc-(S)-α-hydrazinophenylalaninate using 10% NaHCO3/CH2Cl2 to yield dipeptide 
acylated regioselectively at the nitrogen attached to Cα of hydrazinophenylalanine in high yield 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
79 
 
of 92%. The peptide was then converted to the required N-acetylphenylalanyl-α-
hydrazinophenylalanine 261. 
AcHN N
O
NH2
COOH
yield = 88%
N
H
BocHN
COOCH3
CH2Cl2-10% NaHCO3(1 : 1)
FmocHN
R1
N
O
NHBoc
COOCH3
yield = 92%
FmocHN
R1
Cl
O
R2
NHHO H
N
O
COOX
R3
FmocHN
R1
N
O R2
OH
N
H
O
COOX
R3
NaHCO3
CH2Cl2, rt 260258
257 259
261
X = Bn, R1 = (S)-sBu, R2 = iPr, R3 = iPr  (yield = 81%)
X = Bn, R1 = Me, R2 = iPr, R3 = iPr  (yield =86%)
X = Et, R1 = H, R2 = Me, R3 = iBu  (yield = 85%)
X = Et, R1 = Me, R2 = Me, R3 = iPr  (yield = 76%)
R1 = CH2Ph
29
 
Scheme 63. Synthesis of hydrazino-tethered dipeptides and N-hydroxy tethered 
tripeptidomimetics. 
Lawrence et al. synthesized Fmoc-protected inner N-hydroxy tripeptides 258 by selective 
N-acylation of hydroxyl amines with Fmoc-amino acid chlorides under NaHCO3/CH2Cl2 
conditions in 76-86% yields.279 The nature of the base was found to be important, for instance, 
the use of pyridine lead to O-acylated hydroxylamine as the major product.  
6.3.2. N-(Hydroxy)amide and N-(hydroxy)thioamide containing pseudopeptides 
Acid chloride method was explored for the synthesis of N-(hydroxy)amide- and N-
(hydroxy)thioamide containing pseudopeptides 264 without any racemization.280 Acylation of N-
(benzoyloxy)phenethylamine 262 with Fmoc-Leu-Cl 196 resulted in the corresponding amide 
263 in 90% yield. Deprotection of benzoyl group using 10 vol% of NH4OH/MeOH lead to N-
Fmoc-N-(hydroxy)-L-leucine amide in 87% yield (Scheme 64). Further, the thionation of N-
Fmoc-N-(benzoyloxy)-L-leucine amide followed by deprotection of benzoyl group gave the N-
hydroxy thioamide 264. Deprotection of Fmoc group and then extension of chain through 
coupling with another amino acid results in N-hydroxyamide or N-hydroxy thioamide linkages 
into the pseudopeptide oligomers. 
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Scheme 64. Synthesis of N-(hydroxy)amide- and N-(hydroxy)thioamide containing 
pseudopeptides. 
 
6.3.3. Depsipeptides 
Davies et al.281 carried out a comparative study of various coupling reagents and their 
chiral efficacy during the formation of a depside bond in case of Fmoc-L-Ala-L-Phlac-OBn (267) 
(Phlac = phenyllactic acid; Scheme 65). The HPLC analysis of products obtained through 
different coupling conditions revealed that CDI, DCC/DMAP and mixed anhydride methods 
gave nearly 50% yields, whereas TBTU, 2-(5-norbornene-2,3-dicarboximido)-1,1,3,3-
tetramethyluronium  tetrafluoroborate (TNTU) and 2-succinimido-1,1,3,3-tetramethyluronium 
tetrafluoroborate (TSTU) resulted in low yields. Interestingly, using acid chloride method in the 
presence of DMAP, 61% of coupling product could be obtained in 6 h without racemization. But, 
best yields of 83% were obtained using PyBroP coupling at ambient temperature for 3 h. 
FmocHN Cl
O
FmocHN O
O
CO2Bn
+ HO CO2Bn
DMAP
CH2Cl2, 0 oC - rt
 6 h
yield = 61%
266 267265
 
Scheme 65. Synthesis of depsipeptides using Fmoc-amino acid chlorides.  
6.3.4. N-Carboxylalkyl and N-amino alkyl functionalized dipeptides 
Muller et al. reported the synthesis of N-carboxylalkyl and N-aminoalkyl functionalized 
dipeptide units 270 for the assembly of cyclic peptides, in particular, bradykinin and 
somatostatin analogs in solid-phase synthesis.282 N-Alkyl amino acids were initially silylated 
using BSA to the corresponding tetramethylsilane esters (Scheme 66). The coupling with Fmoc-
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amino acid chlorides in presence of DIEA resulted in the required dipeptide building blocks in 
good yields (37-47%) and purity. The resulting Fmoc-protected N-functionalized dipeptide units 
could be employed directly in standard solid phase synthesis.  
 
Scheme 66. Synthesis of N-carboxylalkyl and N-aminoalkyl functionalized dipeptide units. 
6.3.5. 2-Nitrobenzyl backbone modified peptides 
Johnson and Kent283 reported synthesis and photolytic cleavage of 2-nitrobenzyl, 4-
methoxy-2-nitrobenzyl and 4,5-dimethoxy-2-nitrobenzyl backbone modified peptides. Acylation 
of N(2-nitrobenzyl)-glycine-, N(2-nitrobenzyl)-alanine-, N(2-nitrobenzyl)-leucine-, N(2-
nitrobenzyl)-valine-, peptides was studied with increasing bulk of the side chain on the α-carbon. 
Acylation of N-(2-nitrobenzyl)-aminoacyl peptide becomes difficult with increasing bulk of the 
side chain on the α-carbon, with β-branched N-(2-nitrobenzyl)-valyl peptide to be the most 
difficult. Thus, incoming Boc-amino acid (Gly or Val) was coupled to sterically hindered N-(2-
nitrobenzyl)-aminoacyl peptides [test peptide MD(G/V)(X)VK, where X is N(2-Nb)-amino acid; 
test peptide for the N(2-nb)Gly was MG(X)FL] using HOAt active ester (HOAt/DIC and 
HATU), symmetric anhydride (DIC), or acid chloride (BTC). It was reported that only BTC 
method gave quantitative yield for coupling of Boc-Val to N-(2-nitrobenzyl)-alanine (Scheme 
67). Acylation of N-(2-nitrobenzyl)-Leu 271 with Boc-Gly could be achieved in 66% yield, 
whereas other methods lead to unsatisfactory yields. However acylation of N-(2-nitrobenzyl)-
valine by Boc-Gly or Boc-Val was not successful. 
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Scheme 67. Synthesis of 2-nitrobenzyl backbone modified peptides. 
6.3.6. N-Allyl amino peptides 
Patgiri et al.284 reported the solid phase synthesis of hydrogen bond surrogate derived 
helices which involved Fukuyama-Mitsunobu reaction for the synthesis of N-allyl amino 
peptides 274 under microwave irradiation and subsequent difficult coupling to the next Fmoc 
amino acid using BTC method. Coupling of the tert-butyl protected Glu to an allyl amine is 
difficult because of the bulky side chain. Only the BTC activation lead to efficient coupling of N-
allyl alanine residue on Rink amide resin (in XFEA*IYRLELLKAEEAN-NH2; X = pentenoic 
acid residue; A* = N-allyl alanine residue) with Fmoc-Glu(OtBu)-OH in 94% yield without 
racemization, as found by HPLC (Scheme 68). In this case, the reagents including HATU/HOAt, 
TFFH, HOAt and PyBroP/DMAP provided low yields for the difficult coupling.  
 
Scheme 68. Solid phase synthesis of N-allyl amino peptides. 
 
6.3.7. Peptoids: N-1H,1H-Perfluoroalkylated peptides 
Optically pure peptide building blocks with N-1H,1H-perfluoroalkyl label on a selected 
backbone amide bond could be synthesized efficiently using Fmoc amino acid chlorides with 
excess of N-terminus 1H,1H-perfluoroalkylated peptide ester 277 as a base (Schemes 69 and 
70).285 Excess (2 eq) trifluroalkylated peptide ester 278 was condensed with Fmoc-Gly-Cl 275 in 
CH3CN at reflux for 4 h, to obtain peptide building block. After deprotection of Fmoc group at 
the N-terminus, the chain elongation lead to [Leu5]enkephalin 279 possessing N-1H,1H-
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perfluoroalkylated moiety at the desired position. The labeled peptide ester has also been coupled 
to Nα-phthaloyl glycyl chloride 275 in the presence of pyridine, however difficult deprotection 
condition is rather unattractive for the preparation of oligomers. 
 
Scheme 69. Coupling of Fmoc amino acid chloride with N-terminus 1H,1H-perfluoroalkylated 
peptide ester. 
N
Cl
O
reflux, 4 h+
HN
N
H
O
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F3C
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N
H
O
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O
pyridine, CH3CN
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yield = 87%281
282280
 
Scheme 70. Coupling of phthaloyl amino acid chloride with N-terminus trifluroalkylated peptide 
ester. 
6.3.8. Aza-peptides 
Aza-peptides in which one or more of the carbons, bearing side-chain residues, being 
replaced by nitrogen, are one of the important classes of peptidomimetics.286 Systematic 
replacement of amino acid residues in a desired peptide sequence with aza counterparts, namely 
aza-scan has lead to the generation of drug leads and structure-activity relationship studies of 
biologically active peptides. Boeglin and Lubell demonstrated both solution as well as solid 
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phase synthesis of aza-peptides and developed a methodology for the systematic replacement of 
amino acid residues in a peptide with their aza counterparts using Fmoc-aza amino acid chlorides 
as building blocks.287  
Appropriate N'-substituted fluorenylmethyl carbazates 283 were activated with phosgene 
and employed in coupling reactions on Rink resin to obtain aza-peptides with aliphatic, aromatic, 
and heteroaromatic side chains. In SPPS, free amine of growing resin bound peptide was treated 
with three fold excess of requisite Fmoc-aza amino acid chloride 284 and DIEA in CH2Cl2 for 6 
h. After Fmoc deprotection, free aza-amino acid residue was acylated with in situ generated 
Fmoc-amino acid chloride of next amino acid using BTC and 2,4,6-collidine (Scheme 71). 
Acylation using HBTU method failed due to less reactivity of aza-amino acid residue. Using this 
protocol, SPPS of aza-peptide analogs of MCR agonist, a growth harmone secretagogue 
hexapeptide (GHRP-6) and a human calcitonin gene related peptide 289 (hCGRP antagonist) 
were accomplished. 
 
Scheme 71. Solid phase ynthesis of azapeptides using N'-substituted fluorenylmethyl carbazates. 
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Freeman et al. followed similar procedure with due modifications for a microwave 
assisted solid-phase aza-peptide synthesis.288 The application of microwaves reduced the 
standard reaction time and lead to efficient coupling of the aza-amino acid to the growing 
peptide and next amino acid coupling to the aza residue. The protocol was then employed for the 
aza-scan of potent persistently activated protein kinase B (PKB/Akt) inhibitor, PTR6154. 
Freeman et al. also prepared N'-substituted 2-(3,5-dimethoxyphenyl)propan-2-yl-
carbazates (N'-substituted Ddz protected hydrazines) and employed them in the solid-phase aza-
peptide synthesis  using acid labile Rink amide methylbenzhydrylamine (MBHA) resin with mild 
Lewis  acid [Mg(ClO4)2] mediated Ddz deprotection (Scheme 72).289 Thus, Fmoc-Lys-azaVal-
Ala-Ala-Phe-NH2 was synthesized in an overall yield of 50%. N'-Substituted Ddz protected 
hydrazines 290 were treated with excess phosgene in toluene, thus activated aza amino acid 
chlorides 291 were reacted with the free N-terminal amine of the peptidyl resin 292. 
Deprotection of Ddz was carried out using Mg(ClO4)2 in CH3CN at 50 oC. Difficult coupling of 
next Fmoc amino acid to the aza amino acid 293 has been carried out with BTC and 2,4,6-
collidine in CH2Cl2.  
 
Scheme 72. Solid phase synthesis of azapeptides using N'-substituted 2-(3,5-
dimethoxyphenyl)propan-2-yl-carbazates. 
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6.4. Biologically important molecules  
 
6.4.1. Microlin analogs  
Acid chloride strategy was successfully utilized in the synthesis of microlin analogs and 
the strategy allowed insertion of the desired Xaa-pyrrolin-2-one unit which could be explored for 
biological screening.290 Methodology involved silylation of the 5-methyl-pyrrolidin-2-one using 
TMS-Cl/TEA. The purified lactam was reacted with Fmoc-Pro-Cl and Fmoc-Hyp(OBt)-Cl 
(prepared using PCl5 in diethyl ether at -20 oC). The diastereomers 5-R- and 5-S-Fmoc-Xaa-5-
methylpyrrolidin-2-one were separated by RP-HPLC. Following Fmoc deprotection, they were 
reacted with Boc-Thr-MeVal-OH in presence of PyBroP. The TFA deprotection followed by 
coupling with octanoyl-N-methylleucine has lead to the final products. Similar methodology was 
then extended for unsaturated analogs of microlin B 300 as demonstrated by the synthesis of N-
(octanoylprolyl)-5-methyl-pyrrolin-2-one 299 (Scheme 73).  
 
Scheme 73. Synthesis of microlin analogs. 
6.4.2. Azotomycin 
In a nine step total synthesis of (-)-azotomycin, a streptomyces ambofaciens anticancer 
constituent, the key intermediate bis diazoketones 302 from dicarboxylic acid 301 was obtained 
N
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N
O
Unsaturated analog
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by the treatment of diacid chloride with CH2N2 in 39% yield.251,252 Herein the diacid chloride 
was formed by treatment of N-(γ-N-Tfa-Glu-α-OMe)-Glu-Glu-α-OMe 301 with oxalyl chloride 
in dimethylether (DME)-DMF at -30 oC to 0 oC with 50% yield (Scheme 74).  
  
Scheme 74. Synthesis of (-)-azotomycin via diacid chloride intermediate. 
 
6.4.3. L-m-Sarcolysin containing tripeptide esters 
  Weisz et al. employed acid chloride coupling and aminolytic TFA cleavage in synthesis 
of tripeptide ester which possesses antitumor properties.291 The L-m-Sarcolysin, L-m-[bis(2-
chloroethyl)amino]-L-phenylalanine (305) was acylated with N-TFA-L-prolyl chloride (304) in 
an acidic medium in the presence of N,N-dimethylglycine (DMG) in N,N-dimethylacetamide 
(DMA) at 80-90 oC to afford the corresponding dipeptide 306 in 64% yield (Scheme 75). The 
reaction in acidic medium without any added basic reagent, reduces the risk of racemization and 
eliminates the need for deprotection of carboxyl group. The quantity of epimer was found to be 
less than 5%. DMG served as the HCl scavenger. TFA-Pro-Phe[m-(bis(2-chloroethyl)amino)] 
was eventually transformed to the desired final tripeptide ester 307.  
H2N CO2H
N(C2H4Cl)2
N,N-dimethylacetamide
N,N-dimethylglycine
-Cl+H2N
O
H
N
O
N
H
N(C2H4Cl)2
CO2C2H5F3COCN
O
H
N
O
OH
N(C2H4Cl)2
F3COCN
Cl
O
yield = 64% yield = 60%
2 steps
rt to 80-90 oC
304
305
306 307
  
Scheme 75. Synthesis of L-m-Sarcolysin containing tripeptide esters. 
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6.4.4. Hexapeptide precursor of antitumor antibiotic A83586C 
Hale and coworkers employed acid chloride activation for coupling of key fragments in a 
sequential 3+2+1 fragment condensation strategy for the preparation of hexapeptide precursor 
for azinothricin family of antitumor antibiotic A83586C (Scheme 76).292 The dipeptide segment 
310 was constructed by coupling the acid chloride of Fmoc-protected piperazic acid derivative 
309 with the α-hydroxamic acid derivative 308 in a mixture of CH2Cl2 and 12% aqueous Na2CO3 
followed by treatment with TFA in CH2Cl2.  
 
Scheme 76. Coupling of Fmoc-protected piperazic acid chloride derivative 309 with the α-
hydroxamic acid derivative 308. 
Synthesis of tripeptide fragment involved initial coupling of Fmoc-MeAla-Cl 312 with 
(3S)-piperazic acid derivative 313 in the presence of AgCN in toluene at 70 oC for 1 h, to afford 
the dipeptide 314 in 92% yield. However efforts to make use of the two-phase protocol using 
aqueous NaHCO3/CH2Cl2 were unsuccessful. Besides, other carboxyl activating agents such as 
DCC, Ph2P(O)Cl, (PyS)2/PPh3 failed to produce the desired dipeptide which can be attributed to 
the very poor nucleophilicity of the N(2)-atom in N(1)-acylated α-hydrazino acid derivative 
owing to the strong electron withdrawing effect of N-acyl unit and the sterically hindered 
environment around the N(2)-atom. The dipeptide was eventually converted into the required 
tripeptide fragment. 
The dipeptide fragment was then coupled to the Fmoc deprotected tripeptide fragment by 
BOP-Cl activation. The Fmoc protected pentapeptide was deprotected using diethylamine and 
the partially liberated hydrazine was coupled to the final acid chloride unit under reflux in 
toluene in the presence of AgCN to afford the desired hexapeptide 315 (Scheme 77).  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
89 
 
 
Scheme 77. Synthesis of hexapeptide precursor of antitumor antibiotic A83586C. 
6.4.5. Cycloaspeptide E 
Total synthesis of cycloaspeptide E involved the preparation of acyclic pentapeptide 
precursor by Fmoc solution phase synthesis using oxalyl chloride/cat. DMF in good overall yield 
starting from methyl alaninate hydrochloride (Scheme 78).293 Acyclic pentapeptide 317 was then 
cyclized to cycloaspeptide E 318 using the cyclic anhydride propane-1-phosphonic anhydride 
(T3P)294 in 67% yield.  
O
HN COOMe
NH2
1. Fmoc-MePhe-Cl
2. DMAP, CH2Cl2
1. Fmoc-MePhe-Cl
HN OH
OO
NH
NO
O
HN
H
N
O
yield = 67%
HN
O
NH
NO
O
HN
N
O
O
 cycloaspeptide E
yield = 96%T3P in EtOAc
TEA, DMAP
CH2Cl2, rt
316
317
318
1. Fmoc-Leu-Cl
2. DMAP, CH2Cl2 2. DMAP, CH2Cl2
 
Scheme 78. Synthesis of cycloaspeptide E using Fmoc-acid chloride strategy. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
90 
 
6.5. Miscellaneous applications 
 
6.5.1. N-Fmoc-amino acyl-N-sulfanylethylaniline linkers 
Sakamoto et al.295 reported an efficient synthesis of N-Fmoc-amino acyl-N-
sulfanylethylaniline linkers 320, which serve as crypto-peptide thioester precursors for native 
chemical ligation296 applications (Scheme 79). The protocol involved reaction of Fmoc-amino 
acid chlorides with sodium anilides preformed by treating aniline with NaH, at ambient 
temperature. It was found that for sterically less hindered Gly and Ala derivatives, corresponding 
acid chlorides prepared using SOCl2 and catalytic DMF yielded better results. In case of other 
protienogenic amino acids including those with acid labile side chain protecting groups, an 
equimolar mixture of Fmoc amino acid, TEA, and POCl3 (five fold excess over anilide) in 
CH2Cl2 was used for coupling with sodium anilide at ambient temperature for 24 h. The coupling 
conditions lead to good isolated yields of products with negligible racemization. Even in case of 
highly racemization prone Ser(tBu) (< 1%), Cys(Trt) (not detected), His(Mbom) (< 4%) [Mbom 
= 4-methoxybenzyloxymethyl] derivatives, negligible or no racemization was reported. 
 
Scheme 79. Synthesis of N-Fmoc-amino acyl-N-sulfanylethylaniline linkers. 
6.5.2. Mannich type reaction: N-Acylated β-amino acid esters   
In a Mannich-type reaction, Schiff bases 321 are treated with N,N-phthaloyl amino acid 
chlorides 210 and then with the silylketene acetals at room temperature to afford the N-acylated 
β-amino acid esters 325 in moderate to high yields with high diastereomeric ratios (Scheme 
80).297 The stereoselectivity of the reaction found to depend on the steric demand of the amino 
acid side chain as well as the aromatic imine substituents. Whereas the imine from benzylamine 
provided lower diastereomeric ratio, the ortho substituents at either of the aromatic group at the 
imine nitrogen or the carbon atom of the C=N bond tend to increase the stereoselectivity.   
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Scheme 80. Synthesis of N-acylated β-amino acid esters by reaction of Schiff bases with N,N-
phthaloyl amino acid chlorides. 
6.5.3. Arginine compounds: Hydroxamate dipeptidomimetics and Tos-L-Arg chloromethyl 
ketone (TACK) derivatives 
Seo and Silverman reported arginine containing hydroxamate dipeptidomimetics using 
Fmoc-Arg(NO2)-Cl 326 in good yields.298 Due to the weak nucleophilicity of N-
alkylhydroxylamines, use of uronium- or phosphonium-based peptide coupling reagents resulted 
in no isolable product. Formation of lactam side product could be observed in these cases 
(Scheme 81). The use of PyBroP/DIEA system lead to only 8% isolated yield of N-hydroxy 
derivative. However reaction of Fmoc-Arg(NO2)-Cl using SOCl2 at -10 oC to 0 oC followed by 
coupling with N-alkylhydroxylamines in presence of 2,4,6-collidine resulted in hydroxamates 
332 and 330 in 85% and 74% yield respectively.  
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
92 
 
 
Scheme 81. Synthesis of hydroxamate dipeptidomimetics and Tos-L-Arg chloromethyl ketone 
(TACK) derivatives. 
Tos-Arg(NO2)-Cl 326 (prepared by the treatment of Tos-Arg(NO2)-OH with PCl5 in THF 
at -10 to 0 oC) was employed efficiently in the synthesis of Nα-tosyl-L-arginine chloromethyl 
ketone (TACK) in good yield. Tos-Arg(NO2)-Cl was converted to corresponding diazoketone, 
followed by treatment with HCl in acetic acid to yield NG-nitro-TACK. Finally, treatment with 
anisole and anhydrous HF was carried out at 0 oC to yield TACK 328 in 98% yield.299 
Nα-Fmoc-NG-tosylarginine esters were synthesized by the reaction of corresponding acid 
with oxalyl chloride in presence of catalytic amount of DMF, followed by treatment with an 
appropriate alcohol and pyridine. Reaction with methanolic ammonia afforded carboxamide. 
These were then tested as HIV-1 protease inhibitors and found to be relatively specific and 
nontoxic.300 
6.5.4. Acylation of Wang resin  
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Akaji et al. demonstrated esterification of 4-alkoxybenzyl alcohol polystyrene resin in high 
yields with practically no racemerization (< 0.7%) using Fmoc-amino acid chlorides.301 The 
crude Fmoc-amino acid chloride was dissolved in 40% pyridine in CH2Cl2 and vortexed with 
polystyrene-supported Wang resin at 25 oC for 60 min. Except for His(Bom) various amino acids 
with bulky side chain could be obtained quantitatively. The amount of D-isomer was found 
below 0.7% with exception of Met (1.7%). Almost similar results were reported by others 
also.302  
6.5.5. Side chain acid chlorides 
6.5.5.1. N-Hydroxy-L-ornithine  
δ-N-Hydroxy-L-ornithine derivatives 335 were reported by Miller et al. starting from Glu. 
The sequence involved the reduction of -acid chloride 27 to the aldehyde 334, formation of the 
substituted oxime and reductive acylation (Scheme 82).71 Cbz-Glu was treated with 
paraformaldehyde, cat. p-TsOH in toluene to protect the α-amino and carboxyl groups. Further it 
was converted to the corresponding acid chloride followed by reduction to the corresponding 
aldehyde. 
CbzHN CO2H
1. (CH2O)n
PTSA CbzN
O
H
O
yield = 78%
EtOAc, rt
or
Li(OtBu)3AlH
THF, -78 oC
CbzN
O
H
O
yield = 55-85%
CHO
CO2H
COCl
H2N CO2H
N
O
OCH2Ph
2. SOCl2, reflux
27 334
335
(nBu)3SnH
333
 
Scheme 82. Synthesis of δ-N-hydroxy-L-ornithine derivatives. 
 
6.5.5.2. 1,5-N,N'-Disubstituted-2-(substituted benzenesulfonyl)glutamamides 
Srikanth et al.132 reported 1,5-N,N'-disubstituted-2-(substituted 
benzenesulfonyl)glutamamides 338 for the study of quantitative structure activity relationship of 
antitumor activity. Various substituted benzenesulfonyl glutamic acids were prepared by the 
reaction of corresponding benzenesulfonyl chlorides with Glu in 2 N NaOH solution. The 
resultant diacid was converted to the corresponding diacid chloride using SOCl2 under reflux. At 
the end, 2-(substituted benzenesulfonyl)-1,5-N,N-dialkyl glutamamides 338 were obtained by 
addition of acyl chloride 336 to excess of amine under reflux for 30 min in benzene (Scheme 83). 
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Scheme 83. Synthesis of 1,5-N,N'-disubstituted-2-(substituted benzenesulfonyl)glutamamides. 
6.5.5.3. Glycosylated amino acids  
Meldal et al. demonstrated synthesis of fully protected glycosylated asparagine building 
blocks activated as their pentafluorophenyl esters using Nα-Fmoc-Asp(Cl)-OPfp.303 The acid 
chloride was prepared (0.025-5 g scale) from commercially available Nα-Fmoc-Asp(OtBu)-OPfp 
by simultaneous treatment with TFA and SOCl2 at 40 oC for 24 h quantitatively. Nα-Fmoc-
Asp(Cl)-OPfp 339 was then glycosylated with per-O-acetylated β-D-glucose, N-acetyl-β-D-
glucosamine, β-D-mannose, 4-O-β-D-glucopyranosyl-β-D-glucose (cellobiose), 4-O-α-D-
glucopyranosyl-β-D-glucose (maltose) and 4-O-β-D-galactopyranosyl-β-D-glucose (lactose) in 
single step to yield the glycosylated building blocks 341 and 343 (Scheme 84). The condensation 
of the per-O-acetylated glycosyl amines and acid chloride was carried out at 0 oC to result in 36-
91% yield of the desired product with no reaction with the Pfp ester. 
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Scheme 84. Synthesis of glycosylated asparagine building blocks. 
7. Conclusions 
Emil Fischer introduced acid chlorides as peptide coupling agents and the journey came 
to full circle with Louis Carpino reasserting them as efficient and appropriate economical choice 
with the use of Fmoc group. Especially in the sterically hindered peptide couplings involving 
α,α-dialkyl amino acids, N-alkyl amino acids and N-aryl amino acids, clearly the acid chlorides 
are the most efficient when compared with the expensive reagents such as HATU. They can be 
introduced in an automated synthesizer by virtue of being stable in organic solvents like DMF, 
CH2Cl2. Also, in situ generation of acid chlorides has given convenience of not handling them 
directly owing to the problems of hydrolysis and stability. While the diversity of amino acid 
chemistry render a peptide bond formation as a combination of several parameters, as Albericio 
puts it “there is more than one way to skin a cat” and no best single coupling agent yet or in 
future. Though numerous activating agents starting from carbodiimides to active esters, azides, 
anhydrides and other fancy reagents decorated the armory of a synthetic peptide chemist; acid 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
96 
 
chlorides undoubtedly remain the troubleshooter in the case of a difficult synthesis in hand, 
albeit with necessary precautions/modifications. In this regard, new directions to both the 
preparation as well as coupling conditions are the need of the hour. 
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